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Summary 
The ratio of physical particle to infectious virus, or virus specific infectivity (Si), is a central but 
unclear paradox in virus-host cell interactions. We found that a mutant at a threonine residue of 
the immunosuppressive strain of the parvovirus minute virus of mice (MVMi), here named MVMt, 
which resulted in increased capsid phosphorylation, harbored a Si more than one hundred times 
higher than that of the MVMi. The MVMt and MVMi capsids differed from each other in 
biophysical responses to heat stress in vitro, including epitope configurations, genome uncoating 
and disassembly. The increased Si of MVMt seemed to rely on a favored endosomal traffic during 
virus entry into the transformed human kidney cell line (NB324K). Although no increased nuclear 
delivery of the MVMt genome could be demonstrated. This study points to capsid phosphorylation 
as a key unsuspected factor for regulating the efficiency of virus entry. 
 Following nuclear genome delivery, parvovirus infection may lead to its integration into the 
host cell genomes, a process that has allowed multiple RNA and DNA viruses to evolutionary 
colonize the germ line (endogenization) of their hosts. Endogenous parvoviruses and other ssDNA 
virus elements (ESVEs) have been recognized widespread in animal genomes, yet their distribution 
in primates is unknown. We report here the screening for significant ESVEs in human and non-
human primate genomes available in databases. In silico evidences were supported by molecular 
amplification and sequencing of ESVEs and their flanking regions at the  insertion sites in genomic 
DNA samples of primates of which some does not have the genomic sequence data available yet. 
The ESVEs that were originated from ancient or extant uncharacterized viruses highly homologous 
to members of the Dependoparvovirus genus of the Parvoviridae were named Simian 
Dependoparvovirus Elements (SDEs). Most SDEs resulted from four independent insertion events 
along primate evolution. For example, the genome of some members of the Cercopithecidae 
family (as papio, mandrill, or african green monkey) harbored single, or exceptionally double, SDEs 
homologous to AAV2. Many SDEs conserve the catalytic and structural domains of Rep and the 
capsid genes, although the length of sequences varied. These findings provide novel insights of the 
potential biological significance for primate evolution. 
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Resumen 
La relación partícula física / virus infeccioso, o infectividad específica (IE), es una paradoja central 
pero poco clara en las interacciones virus-célula huésped. Encontramos que un mutante en un 
residuo de treonina de la cepa inmunosupresora del parvovirus diminuto de ratón (MVMi), 
llamado MVMt, que aumenta la fosforilación de la cápsida, alberga una IE más de cien veces 
mayor que la de la del MVMi. La cápsida del MVMt difirió de la de MVMi en las respuestas 
biofísicas al estrés por calor in vitro, incluída la configuración de epítopos, desencapsidación del 
genoma y desensamblaje. El aumento de IE del MVMt parece depender de un mejor tráfico 
endosomal durante la entrada del MVMt en células humanas transformadas (NB324K). Aunque no 
se pudo demostrar un aumento en la entrega nuclear de su genoma. Este estudio apunta a la 
fosforilación de la cápsida como un factor insospechado pero clave en la regulación de la eficacia 
de la entrada de virus. 
Tras la entrega del genoma en el núcleo, la infección por parvovirus puede conducir a la 
integración en el genoma de las células, un proceso que ha permitido que virus de ARN y ADN 
colonicen evolutivamente la línea germinal (endogenización) de sus hospedadores. Muchos 
parvovirus endógenos y otros elementos de virus ssDNA (ESVE) se han identificado ampliamente 
distribuidos en genomas de animales, aunque se desconoce su distribución en primates. 
Presentamos aquí el cribado de ESVE en el genoma de humanos y algunos primates no humanos 
disponibles en las bases de datos. Las evidencias in silico se apoyaron por amplificación molecular, 
y la secuenciación de las ESVE y sus regiones flanqueantes en los sitios de inserción, utilizando 
muestras de ADN genómico de primates, algunas de las cuales sin que la secuencia de su genoma 
esté accesible en bases de datos. Los ESVE identificadas, que se originaron a partir de virus 
antiguos o existentes en la actualidad, pero no caracterizados, son altamente homólogos a los 
miembros del género Dependoparvovirus de la familia Parvoviridae, y los hemos denominado 
Elementos Dependoparvovirus de Simio (SDE). La mayoría de las SDEs resultaron de cuatro 
eventos de inserciones independientes a lo largo de la evolución de los primates. Por ejemplo, el 
genoma de algunos miembros de la familia Cercopithecidae (como papio, mandrill, o mono verde 
africano) alberga SDE únicos, o excepcionalmente dobles, homólogos a AAV2. Muchas SDEs 
conservan los dominios catalíticos y estructurales de las proteínas Rep y Capsida, aunque las 
longitudes de las secuencias son diversas. Estos hallazgos proporcionan nuevos conocimientos que 
podrían tener un significado biológico para la evolución de los primates. 
Datos Protegidos 
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 Introduction 
Introduction 
Section A.  
1. General principles of virus entry. 
Viruses recognize and attach to macromolecules of different natures, on the cell surface acting as 
receptors. In a productive infection, attachment to the suitable receptor allows viral particles to 
internalize and start the infection. Entry is the earliest process of the virus life cycle, a key step of 
the unique capacity of viruses to deliver their nucleic acid into the host cell. 
There are several events and factors to be considered when studying viral entry, such as 
attachment, signaling, fusion with the plasma membrane, endocytosis, endosomes, penetration, 
intracellular transport and uncoating. Upon receptor interaction, the receptor-mediated 
endocytosis triggers the trafficking of virus across the endosome. The endosome is characterized 
by its mild acidic pH that descends from 6.5 to 5.5 in early to late endosomes, and finally it ranges 
from 5 to 4.5 when the endosome is fused with lysosomes forming endolysosomes where 
proteolytic degradation occurs. These changes of pH are mainly due to  the activity of the ATP-
dependent proton pumps present in the membrane of both endosomes and lysosomes (Diering 
and Numata, 2014; Hu et al., 2015; Yamauchi and Helenius, 2013). 
The trafficking across endocytic pathways is regulated by membrane associated proteins belonging 
to the Rab family GTPases. Each endocytic compartment has a unique Rab protein that could be 
used as specific marker (Agola et al., 2011; Hutagalung and Novick, 2011). One of the most 
important processes in this study is the traffic of non-enveloped icosahedral viruses across the 
endosomal compartment leading to viral entry, which was best studied in Poliovirus (Hogle, 2002), 
Adenovirus (Luisoni and Greber, 2016) and Polyomavirus (Tsai and Qian, 2010). In these virus 
systems a diversity of interacting factors and molecular triggers are accessed by the incoming 
particles to progress across the endosomal compartments, while profound structural 
rearrangements and proteolytic cleavage of the capsid, by different pH dependent or independent 
processes, allow complexes of capsid protein-nucleic acid reach the cytosol, and for the karyophilic 
viruses enter the nucleus (Hogle, 2002; Luisoni and Greber, 2016; Tsai and Qian, 2010).  
 2 
 
 
2. The Parvoviridae. 
2.1. Taxonomic structure of the family   
The Parvoviridae is a family of small, non-enveloped, icosahedral viruses with linear single-
stranded DNA (ssDNA) genomes, infecting an exceptionally wide range of animal hosts, from 
invertebrates to mammals, including humans. Diseases caused by parvoviruses in their natural 
hosts vary in severity from subclinical to lethal infections, depending on the virus and host factors 
such as age, immune-competence and health conditions (Kailasan et al., 2015). A condensed 
version of the taxonomic structure of the family is shown in Figure 1 (Cotmore et al., 2014). The 
present study concerns mainly to the Adeno Associated Virus (AAV) of the Dependoparvovirus 
genus, and the Minute Virus of Mice (MVM) of the Protoparvovirus genus. Protoparvovirus (PtPV), 
is a genus of the Parvovirinae sub-family currently including the following species: Rodent 
protoparvovirus 1 (H-1 parvovirus (H-1PV), Kilham rat virus (KRV), LuIII virus, minute virus of mice 
(MVM), mouse parvovirus (MPV), tumor virus X (TRX), rat minute virus (RMV) ); Rodent 
protoparvovirus 2 (rat parvovirus 1); Carnivore protoparvovirus 1 (canine parvovirus (CPV) and 
feline panleukopenia parvovirus (FPV); Primate protoparvovirus 1 (bufavirus (BuV) ) and Ungulate 
parvovirus 1 (porcine parvovirus (PPV).  
 
 
 
 
 
  
 
 
Figure 1. Parvoviridae taxonomic classification.  
The subfamilies and genera of this family of viruses are displayed as proposed in the last version 
by the International Committee on Taxonomy of Viruses (ICTV), and the species belonging to 
Protoparvovirus genus are shown in the right.  
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2.2. Genome organization of the PtPV. 
The PtPV ssDNA genome, of approximately 5 kb in length, is organized in two open overlapping 
transcriptional units (Figure 2), timely regulated (Cotmore and Tattersall, 1987; Tullis et al., 1988). 
The left hand sequence driven by the P4 promoter encodes the NS1 and NS2 nonstructural 
proteins, and the right hand sequence driven by the P38 promoter encodes the VP1 and VP2 
structural proteins. In spite of its small size, the parvovirus genome has maximized the coding 
capacity by alternative splicing, extensive post-translational modifications and proteolytic 
processing. 
 
 
 
 
 
 
 
 
Figure 2. Schematic view of the organization of MVM genome.  
The P4 promoter is used for NS1 and NS2 transcription and the P38 promoter is used for VP1, VP2 
and VP3 transcription. The open reading frames (ORFs) are shown in boxes with different colors.  
 
2.3. Functions of the parvovirus NS proteins.  
Both NS polypeptides encoded by most PtPVs play multiple roles in virus life cycle. The smaller NS 
protein, NS2 protein (28 kDa), contains three isoforms arising from alternate splicing that can bind 
several cellular proteins and shuttle them from the nucleus to the cytoplasm via the Crm1 export 
pathway (Miller and Pintel, 2002). Functions assigned to NS2 include assisting capsid assembly 
(Cotmore et al., 1997), messenger translation (Naeger et al., 1993), DNA replication and virus 
production in a cell type specific manner (Naeger et al., 1990). The larger NS protein, NS1 (82 kDa), 
is a multifunctional nuclear phosphoprotein, highly toxic for most cells, which performs crucial 
activities such as DNA-binding, Nickase, ATPase and helicase in the MVM unique rolling-hairpin 
mode of DNA synthesis (Cotmore and Tattersall*, 1995; Deleu et al., 1997; Hörlein et al., 2002; 
Miller and Pintel, 2002; Mouw and Pintel, 1998; Nüesch et al., 1995; Nüesch and Tattersall, 1993). 
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2.4. The structure of parvovirus capsids.  
The parvovirus capsid is a 25 nm-diameter assembly of 60 subunits in a T = 1 icosahedral 
symmetry formed by two to four largely overlapping proteins commonly designated VP1 to VP4 
(Tijssen et al., 2012). The 3-D atomic structure of PtPV capsid is available for many virus members 
of the family (Figure 3). Common features are the folding of their protein subunits into an eight-
stranded antiparallel β-barrel topology, a β-cylindrical projection encircled by a canyon-like 
depression that surrounds the fivefold symmetry axes, and a pore at the center of the β-cylinder 
running between the surface and the interior of the capsid. The topology of the capsid surface 
differs among parvoviruses conferring characteristic virus host range. Flexible domains in the 
capsid are the N-terminal sequences of the VP subunits, which are dispensable for virus assembly, 
but strictly required for infection, as they contain functional motifs that can be hidden or exposed 
on the capsid surface at specific host cell compartments to mediate virus entry (Farr et al., 2005; 
Lombardo et al., 2002; Vihinen-Ranta et al., 2002; Zádori et al., 2001) and egress (Maroto et al., 
2004). 
 
 
 
 
Figure 3.  Six representative parvovirus capsid structures.  
The cryo-reconstructions shown (7.9 Å resolution), with corresponding 2-fold views of B19, AAV2, 
AMDV, MVM, and GmDNV, highlight similarities and differences in the outer surfaces of the 
capsids. Vertical bar depicts color cueing as a function of particle radius in Å ( from Gurda et al., 
2010) 
 
3. The protoparvovirus life cycle. 
It has been recently reported that the consecutive steps of the parvovirus life cycle (gene 
expression, nuclear translocation of proteins, capsid assembly, genome replication and 
encapsidation) are tightly coupled to the host cell cycle progression (Gil-Ranedo et al., 2015). 
Importantly, parvovirus MVM gene expression in synchronous infections occurred at G1/S, 
implying that transcription does not require a previous viral DNA amplification, which indeed 
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occurred later at S/G2 phase.  Capsid formation is particularly sensitive to cell cycle regulation, 
which is exerted at the level of non-conventional nuclear transport route(s) accessed by the 
assembly intermediates (Figure 4).  Indeed, signals perturbing the cell cycle, as density arrest 
contacts or DNA synthesis stress, deregulate MVM nuclear capsid assembly. 
 
 
 
 
 
 
Figure 4. The coupling of Parvovirus MVM and cell host life cycles. 
A: Parvovirus assembly and maturation is timely coupled to cell cycle progression from G1 to G2. 
Phosphorylated VPs trimers translocate into the nucleus at early S phase driven by the nuclear 
localization motif (NLM) (Lombardo et al., 2000), and assemble into empty capsids. Viral genome 
replication () and virions maturation occur as cells become arrested at the late S/G2 phases by the 
infection. B: Infected cells subjected to cell cycle stress by thymidine DNA replication or density 
cell contacts (DA), interrupt drastically VPs nuclear transport, resulting into cytoplasmic empty 
capsids formation. C: cytoplasm, N: nucleus, NPC: nuclear pore complex and vDNA-RF: viral DNA 
replicative form. (taken from Gil-Ranedo et al., 2015, with permission). 
 
This coupling of parvovirus assembly to the cell cycle may largely rely on the control of capsid 
subunit phosphorylation. In MVM infection, the VP1 and VP2 structural subunits assembled into 
empty capsids were post-translationally modified through a complex and VP-specific pattern of 
phosphoserine and phosphothreonine residues (Maroto et al., 2000). The 3-D structure of virus-
like particles (VLPs) was obtained at high resolution (Hernando et al., 2000), even though lacked 
phosphorylation (Riolobos et al., 2010) and assembled in the cytoplasm of insect cells (Riolobos et 
al., 2010; Yuan and Parrish, 2001), indicating that, at least for the VP2-only capsid, subunit 
phosphorylation is not important for icosahedral T=1 ordering.  
However, nuclear transport of the VP2 homotrimer required cytoplasmic phosphorylation by the 
Raf-1 kinase (Riolobos et al., 2010), although this phosphorylation was not sufficient to explain its 
cell cycle-regulated transport (Gil-Ranedo et al., 2015). Raf-1 phosphorylation targets serine 
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residues of 2Nt (Maroto et al., 2000), but localization of the many other phosphorylation sites in 
the VP1 and VP2 capsid subunits and their functions in the steps of the viral life cycle are 
unknown. It has been recently reported (Gil-Ranedo et al., 2018) that the VP1 subunits are 
hyperphosphorylated in cytoplasmic assembly intermediates, but are subjected to an orchestrated 
dephosphorylation program during assembly that correlates with changes in Nt configuration (see 
Figure 5). These processes may help understanding virus/cell life cycles coupling.  Furthermore, 
empty and DNA-filled virus particles drastically differed in the phosphorylation status of their VP1 
and VP2 protein subunits, suggesting that genome encapsidation may imply VPs-
dephosphorylation (Gil-Ranedo et al., 2018). 
 
 
 
 
 
 
 
Figure 5. Capsid subunits phosphorylation in MVM life cycle.  
The figure illustrates the differential phosphorylation levels and the exposure of the Nt-domains of 
the VP1, VP2 and VP3 structural proteins (respective numbers in this figure) in the complexes that 
traverse the cytoplasmic and nuclear membranes during the MVM infection cycle. The G1, S, and 
G2 letters (connected by arrows above in the figure) refer to the cell cycle steps at which virus 
assembly and maturation preferably occur. The VP protein subunits in the viral particles and 
assembly intermediates are depicted at their estimated stoichiometry. The VP1-Nt and VP2-Nt 
domains are only illustrated in exposed configuration(s) accessible to antibodies. R: Virus receptor; 
NPC: Nuclear pore complex. (taken from Gil-Ranedo et al., 2018, with permission). 
4. Protoparvovirus entry into cells. 
The PtPV entry, includes a diversity of processes such as virus-cell interactions, sequential 
exposure of structural protein domains and capsid rearrangements (reviewed in Cotmore and 
Tattersall, 2007; Harbison et al., 2008; Parrish, 2010; Ros et al., 2017; Vihinen-Ranta et al., 2004). 
As summarized below, starting from the initial interaction with host cell receptors, the incoming 
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PtPv viral particle undergoes sequential steps leading to delivery of its ssDNA genome into the 
nucleus.  
4.1. Receptors use.  
Different types of biomolecules, such as proteins and carbohydrates, have been identified as 
attachment factors and in some cases as functional receptors for members of the PtPV genus. One 
of the best studied examples is the interaction of transferrin receptor (TfR) with CPV and FPV. 
These viruses use TfR to bind and infect cells (Parker et al., 2001). Binding to TfR correlates with 
host specificity of these viruses, as FPV binds the feline TfR only, while CPV binds both the canine 
and feline TfRs. CPV variants accumulates changes on the top and side of the three-fold spike of 
the capsid surface, which confer more efficient use of the canine TfR receptor and reduce binding 
to the feline TfR (Hueffer et al., 2003, 2004). The receptor residues involved in binding localize to 
the TfR apical domain and substitution of single amino acid may shift TfR binding ability to CPV or 
FPV (Palermo et al., 2003, 2006). The TfR molecules asymmetrically associated in vitro with a few 
of the sixty icosahedral equivalent binding sites on the CPV capsid near the three-fold axis of 
symmetry (Figure 6). The TfR-CPV capsid interaction may be compromised by alteration of key 
residues of both the receptor and the virus capsid binding domain (Kaelber et al., 2012), such as 
mutations at residues 206–380 of the TfR apical domain that reduce binding to CPV capsids. In 
particular, the N-linked glycosylation site at position 384 in the canine TfR provided resistance to 
the carnivore parvoviruses that were circulating prior to about 1975. Later a variant virus was 
emerged that overcame this block (Allison et al., 2014). The use of TfR receptors by CPV and FPV 
variants illustrates the capacity of the PtPV to adapt to receptors determining host range. 
The Sialic acid (SA; N-acetyl neuraminic acid) glycan is another well-characterized PtPV receptor 
and probably the most commonly used in nature. Glycans represent major cell surface 
carbohydrate components, thereby provide a vast collection of cellular attachment factors for 
many viruses (Olofsson and Bergström, 2005). Biochemical studies have shown SA to serve as a 
common primary attachment factor for several PtPV, although the difference between unspecific 
attachment and functional interaction (as a receptor leading to infection), has only been clarified 
in a few viral systems. SA was first suggested to play a role as MVM binding site to cell surfaces 
(Cotmore and Tattersall, 1987), in the range of 4–8 × 105 SA molecules per cell in established cell 
lines (Linser et al., 1977; Spalholz and Tattersall, 1983) and primary host cells (Rubio et al., 2005). 
It was subsequently demonstrated that SA acts as functional receptor for the infection of MVM 
(Lopez-Bueno et al., 2006), PPV (Boisvert et al., 2010) and H1-PV (Allaume et al., 2012) PtPv.  
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Figure 6. Structures of receptor-protoparvovirus capsid complexes. 
A: Asymmetric binding of transferrin receptor to the CPV capsid. The image illustrates a TfR dimer 
placed manually into the cryoEM density of CPV capsid. The interaction is best resolved between 
one of the two apical domains of the TfR dimer (green) and the shoulder of a spike near a 
threefold icosahedral axis of CPV capsid. (Reproduced with permission from Hafenstein S. et al., 
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6585-9. Copyright (2007) National Academy of 
Sciences, U.S.A.). B and C: X-ray crystal structure identifying an infectious receptor attachment site 
on the parvovirus MVMp capsid soaked with sialic acid, showing the sugar electron density 
allocated in the twofold pocket (Reproduced with ASM permission from (Lopez-Bueno et al., 
2006). 
 
4.2. Protoparvovirus uptake by the host cell.  
Upon host receptor interactions, the PtPVs are internalized mainly by classical endocytosis 
(Clathrin-mediated endocytosis: CME). The endocytic route offers numerous advantages for the 
karyophilic parvoviruses. Endosomes provide a rapid and efficient transport for viruses, as the 
endolysosomal microenvironment with increasing acidic milieu and the changes in redox 
conditions, acid proteases and phosphatases enable capsids to undergo the structural 
conformational changes required for the infection, and eventually lead to the endosomal escape. 
But in addition to the classical CME, PtPV may use several alternative endocytic routes such as 
micropinocytosis (Boisvert et al., 2010). Indeed MVMp may enter host cell by at least three 
potential endocytic routes (Garcin and Panté, 2015), mediated by clathrin, caveolin, and clathrin-
independent carriers, the later restricted to transformed cells. Thus, both clathrin- and caveolin-
mediated MVM endocytosis are dependent on dynamin in normal cells, but transformed cells 
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allow dynamin-independent mediated uptake of MVMp. These observations imply that although 
internalization by clathrin might represent the main entry route of PtPV, other alternative routes 
of uptake might be involved in parallel in certain cell types. 
4.3. Endosomal traffic and capsid processing.  
The endosomal processing of the incoming PtPV particles is essential for the infection. The 
endolysosomal microenvironment triggers crucial capsid structural rearrangements, and this 
process may be slow. MVM only reaches the cell nucleus after 8 hours post infection (hpi) when 
the DNA replication was detected and lysosomotropic drugs impaired the infection (Bowman et 
al., 1988; Vihinen-Ranta et al., 1998). For example, bafilomycin A1, which raise the endosomal pH 
by inhibiting the vacuolar-type H+ -adenosine triphosphatase (ATPase) (Hensens et al., 1983; 
Ohkuma and Poole, 1978), or the weak base chloroquine diphosphate (that accumulates inside 
acidic compartment) inhibited MVM infection (Mani et al., 2006). Endosomal acidification has 
been demonstrated to be essential for the infection of other parvoviruses (Basak and Turner, 
1992). 
The rearrangements that PtPV capsids undertake along entry can be traced by the configuration 
and functions of the N-terminal sequences of the VP1 and VP2 subunits. The amino termini of VP1 
(VP1-Nt, 1Nt or VP1uR) and VP2 (VP2-Nt or 2Nt) are flexible domains whose configuration cannot 
be resolved in the X-ray crystal structure of PtPV capsids (Agbandje-McKenna et al., 1998; Kontou 
et al., 2005; Tsao et al., 1991), and are normally concealed in their interior. These sequences carry 
essential transport signals and are thought to translocate across the five-fold channel of the 
capsid. This led to the suggestion that VP N-termini act as drivers of the traffic of intact virions 
across the cellular compartments along the virus life cycle (Maroto et al., 2004). The 
externalization through the parvovirus fivefold capsid channel has been studied in detail for the 
VP2-Nt in virus like particles (VLPs) and native capsids (Castellanos et al., 2013; Cotmore et al., 
1999, 2010; Farr et al., 2006; Hernando et al., 2000; Reguera et al., 2004; Suikkanen et al., 2003) . 
The dynamic exposure of Nt sequences across the channel is regulated by amino acid residues 
lying at the base of the pore, some of them configuring a hydrophobic gate tightly controlling the 
externalization of VP2-Nt and VP1 Nt sequences (Farr and Tattersall, 2004; Subramanian et al., 
2017). The VP2-Nt plays an elusive function during the virus entry process. This domain may be 
cleaved in vitro to form the VP3 protein by a chymotrypsin-like protease (Paradiso, 1981; Paradiso 
et al., 1984; Tattersall et al., 1977; Tullis et al., 1992), and in vivo the VP2 to VP3 cleavage occurs in 
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the pH-dependent entry pathway, soon after PtPV internalization. Neither the resulting VP3 nor 
VP1 subunits can accomplish the essential entry function(s) harbored by the VP2-Nt domain 
(Sánchez-Martínez et al., 2012). Therefore, it was proposed that the short VP2-Nt sequence may 
enlarge the functional diameter of the viral five-fold pore inside the endosome, determining the 
sequential exposure of VP2-Nt and VP1-Nt in the incoming metastable PtPV virion (Sánchez-
Martínez et al., 2012). 
4.4. Endosomal escape and VP1 functions. 
As other non-eneveloped viruses, the PtPV must penetrate, disrupt or breach, the host cell’s 
delimiting membrane during entry, thereby undergo endosomal escape. But, the endosomal 
escape represents a major barrier for successful PtPV infection. Taking MVM as an example, a 
substantial proportion of the incoming MVM virions was demonstrated to follow a non-infectious 
pathway ending up in lysosomal compartments where they co-localized with lysosomal markers 
(Mani et al., 2006). The PtPV endosomal escape depends on the profound capsid structural 
rearrangements occurring inside the endosome (see above), which lead to the externalization of 
the disordered VP1-Nt carrying a lipolytic activity (PLA2) that penetrates the endosomal 
membrane (Zádori et al., 2001). The VP1-Nt becomes exposed in early endocytic vesicles (Cotmore 
and Tattersall, 1989; Farr et al., 2005; Mani et al., 2006). Complementation assays between wild-
type and mutant MVM particles have been used to demonstrate the role of PLA2 in mediating 
phospholipid bilayer penetration (Farr et al., 2005). However, the precise site of PtPV endosomal 
escape is still incompletely understood. The optimal pH for the parvoviral PLA2 enzymatic activity 
ranges between pH 6 to 7, but this activity drastically decreases at a pH below 5 (Canaan et al., 
2004). Additionally, brefeldin A, an antibiotic blocking the transition between early and late 
endosomes has been demonstrated to abrogate MVM infection (Ros et al., 2002). These results 
suggest that only a minority of virions that enter the cytosol escape from an intermediate pre-
lysosomal vesicle, namely late endosomes (Mani et al., 2006). 
4.5. Nuclear targeting and uncoating of the Protoparvovirus virion.  
The transport of macromolecules through the nuclear pore complex (NPC) into the nucleus is a 
highly selective process mainly mediated by nuclear localization signals (NLS) exposed on the cargo 
molecules and recognized by specialized transport proteins (Timney et al., 2016; Wente and Rout, 
2010). The NPC central channel has a functional diameter up to a maximum of 39 nm, in the range 
of the diameter of the parvovirus capsids. Therefore, unlike larger viruses, which partially or 
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completely uncoat prior translocation through the NPC (Fay and Panté, 2015), the incoming 
parvovirus particle could pass through without disassembly. Two distinct mechanisms have been 
proposed for the nuclear entry of incoming PtPV: (i) PtPV particles translocate across the NPC 
mediated by exposed NLS in the VP1 unique region (Boisvert et al., 2014; Lombardo et al., 2002; 
Vihinen-Ranta et al., 1997) and  (ii) NPC-independent nuclear entry following local disintegration 
of the nuclear membrane (Cohen et al., 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Model of PtPV cell entry and nuclear import. 
(1) In the productive infection, PtPV capsids bind to one or more cell receptors with adequate 
affinity. (2) Following lateral diffusion, capsids are captured by pre-formed or forming clathrin pits 
(3) or otherwise become detached from their receptors. (4) Capsids are internalized via clathrin-
mediated endocytosis (5) and enter the endocytic pathway where the low pH environment and 
local enzymes trigger structural rearrangements. (6) Major structural changes are a de novo VP2 
N-terminus exposure and cleavage, and particle dephosphorylation, leading to VP1u exposure 
through the channel. The endosomal trafficking may vary in complexity and time, but commonly 
only a small proportion of particles escape after altering the endosomal membrane through the 
activity of the VP1-encoded phospholipase A2. (7) Many incoming infectious particles fail to escape 
from endosomes and are routed to and accumulated in the degradative lysosomes. (8) In the 
cytosol, parvoviruses exploit the cytoskeleton and motor proteins to move to the nuclear vicinity. 
(9) It is not yet clear how the viruses and/or their genomes enter the nucleus, as nuclear pore-
dependent entry and permeabilization of the nuclear envelope have been proposed. (10) The site 
and timing of capsid uncoating are also uncertain processes (Reproduced from Ros et al., 2017). 
In the later mechanism, the initial interaction of incoming PtPV capsids with NPC proteins would 
cause capsid structural rearrangements, which initiate a signal cascade resulting in local nuclear 
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envelope disintegration. These apparently contradictory observations may however function in 
concert to promote PtPV nuclear entry. An initial docking of the PtPV capsids to the NPC could 
trigger a local disintegration of the nuclear envelope, which would facilitate the transport of the 
capsids across the NPC. Finally, the mechanism and intracellular site of PtPV uncoating is not well 
understood (Figure 7). 
 
5. The MVM (i,p) biology. 
5.1. Cell hosts of MVMp and MVMi determining tropism in vitro and in vivo.  
Tropism is a major pathogenic factor for infectious agents. Both host range variants of MVM, the 
lymphohematotropic (MVMi) and fibrotropic (MVMp) strains (Bonnard et al., 1976; Crawford, 
1966), provide a useful model for the study of DNA virus tropism in disease of a mammal host. 
MVM tropism is predominantly controlled by the gene encoding the 25nm-diameter T=1 
icosahedral capsid (Ball-Goodrich and Tattersall, 1992; Maxwell et al., 1995), that consist of two 
proteins, the VP2 (64 kDa), and VP1 (83 kDa) polypeptides. Although MVMp and MVMi differ only 
at  few residues in VP2, they are reciprocally restricted for growth in each other's host cell type at 
a point after attachment to the cell surface receptor but prior to the onset of viral gene expression 
and DNA replication (Spalholz and Tattersall, 1983; Tattersall and Bratton, 1983). In established 
cell lines in vitro, two amino acid residues in MVMi, at VP2 codons 317 and 321, act coordinately 
as major determinants for the acquisition of fibrotropism (4), whereas the switch to 
lymphotropism for MVMp requires both an equivalent region of the MVMi coat protein gene and 
a segment of the non-structural (NS) protein genes (Hirt et al., 1998).  
In mice, MVMi is pathogenic for the newborn (Brownstein et al., 1991; Ramírez et al., 1996), and 
in severe combined immunodeficient (SCID) adults causes a depletion of hemopoietic precursors 
in bone marrow leading to severe leukopenia and accelerated erythropoiesis (Segovia et al., 1999), 
which results from the ability of this virus to target committed, as well as long-term repopulating, 
hemopoietic stem cells (Segovia et al., 1991, 2003). In contrast, MVMp is apathogenic in newborn 
mice (Kimsey et al., 1986), and in oronasally-inoculated adult SCID mice its infection is 
asymptomatic with no clinical morbidity (Rubio et al., 2005). However in intravenous inoculations 
MVMp evolves to pathogenic variants carrying single changes in the VP gene (Lopez-Bueno et al., 
2006; López-Bueno et al., 2006). 
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5.2. Receptor use by the MVM strains.  
The molecular basis of the distinct tropism of the MVM (p, i) strains has been a matter of intense 
debate. The interaction to the natural SA receptor used by both MVM strains should likely be 
involved with the tropism, and it has been consequently studied. Binding to an array of glycans 
enabled identification of SA types recognized by the two natural MVM strains, as well as by the 
emerged virulent capsid variants mentioned above (Nam et al., 2006), and supported the 
evidences that lower affinity to SA glycans, rather than a different SA receptor specificity, 
determines MVM virulence (Lopez-Bueno et al.). However, it remains unclear how capsid binding 
to SA-glycans may determine MVM tropism in vitro and in mice. Tropism determinants of MVMp 
and MVMi capsids in vitro mapped to a few residues which also localized to the two-fold dimple 
(Antonietti et al., 1988; Ball-Goodrich and Tattersall, 1992; Gardiner and Tattersall, 1988; 
Tattersall and Bratton, 1983). However, the N- and O- glycans and polar glycolipids composition of 
the cell lines used in those studies failed to explain MVM tropism solely based on the SA cell 
surface composition (Halder et al., 2014), suggesting the requirement of other cellular factors. 
MVMp undergoes a remarkable switch of tropism from asymptomatic fibrotropic to pathogenic 
hematotropic behavior upon weeks post- infection in scid mice (Lopez-Bueno et al., 2008). This 
dramatic change in pathogenicity involved the emergence of a heterogeneous viral population 
harboring multiple genetic changes, which were strictly confined to the surface of the dimple 
surrounding the SA-receptor binding pocket (Lopez-Bueno et al., 2008). Therefore, the capsid 
residues mediating direct contact with SA are major determinants of MVM virulence and tropism 
along its evolution in mice. Further research will be required to elucidate whether these 
genetically heterogeneous variants co-operate to cause disease, use different SA molecules to 
infect distinct hematopoietic precursors, or arise in naturally infected host settings. 
6.  Biomedical applications of PtPv.  
The biological relevance of the virus members of the Parvoviridae is not only due to their 
pathogenicity in their natural host, as two major biomedical applications can be outlined. Firstly, 
AAV2, the best study serotype of the Dependoparvovirus, is being developed as suitable vector for 
gene therapy of genetic diseases in human and animals e.g. Balazs et al., 2012; Ran et al., 2015.  
Secondly, AAV2 and some of the rodent PtPVs as H-1PV, MVM and LuIII, do display natural 
oncotropism and marked oncolytic activities against human cancer cells (Rubio et al., 2001). The 
natural oncotropism of parvoviruses is determined, at least in part, by the fact that Parvovirus 
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replication is strongly dependent on host cell factors expressed during the S-phase, due to the 
limited coding capacity of the genome and their inability to induce resting cells to enter S-phase 
(Bashir et al., 2000; Weitzman MD, 2006). Moreover, the virus cycle, particularly the nuclear 
translocation of structural subunits and capsid assembly, are tightly coupled to the cycle of the 
host cell (Gil-Ranedo et al., 2015). The dependency on poorly characterized transformation factors 
could be the reason of the high susceptibility of certain human tumor cells to Parvovirus induced 
killing (Angelova et al., 2015; Nüesch et al., 2012; Riolobos et al., 2010; Ventoso et al., 2010). 
Therefore, these features, the non-pathogenicity for humans, and the low prevalence of pre-
existing antibodies, make parvoviruses promising tools to treat some human tumors (Marchini et 
al., 2015). 
7. The oncolytic MVMt.  
 MVM exhibits oncolytic potential (Rubio et al., 2001). We have previously attempted to enhance 
MVM oncolysis by engineering the NS proteins with novel functional and biochemical activities. 
The NS1 protein of the immunsupressive strain MVMi was manipulated by site-directed 
mutagenesis at different residues that may control post-translational modifications of this large 
polypeptide. While most mutants yielded non-viable viruses or a neutral phenotype, a single 
mutant at a Threonine residue resulted in a viable virus with apparent high multiplication 
capacity in culture (Guerra et al, 2000).  This MVMi mutant virus, here named MVMt, could be 
produced and purified at large scale and was therefore subjected to further analysis of infectivity 
and capsid properties as described in this work. The effects that the NS1 mutation brings to the 
biochemical and replicative properties of this protein are currently under investigation.   
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Section B 
1. Endogenous Viruses 
Viruses are common pathogenic infectious entities, but virus-host interactions may also develop as 
complex non-pathogenic patterns and symbiosis, an even in some cases the host may benefit from 
the virus infection. ((Jagdale and Joshi, 2018; Roossinck and Bazán, 2017). In some situations 
viruses may infect germ line cells of organisms along evolution, and become integrated and 
inherited as endogenous virus elements (EVEs) into their chromosomes (Feschotte and Gilbert, 
2012) Most EVEs are RNA+ viruses of the Retroviridae (ERV) widely represented in vertebrates, 
including mammals and primates (Weiss and Stoye, 2013)). Human endogenous retroviruses 
(HERVs) have invaded primates and human genomes as several waves along phylogeny.  
However, non-retrovirus RNA viruses can also persist as endogenous DNA elements (Zinkernagel 
et al., 1997), and recently many families of RNA+, and RNA- viruses, have been identified widely 
represented as endogenous elements in multiple organisms (Crochu et al., 2004; Horie et al., 
2010; Taylor et al., 2010). Flaviviruses in invertebrates (Crochu et al., 2004), Filoviruses (Taylor et 
al., 2010) and Bornaviruses in human and mammalian genomes (Horie et al., 2010), are 
noteworthy examples. 
2. Endogenization mechanisms of RNA viruses. 
The efficient Retrovirus endogenization as DNA elements is linked to the fact that they are the 
only animal viruses requiring integration into the host genome during their life cycle. As integrated 
provirus the Retrovirus genome may be activated, remain latent, or be recombined and deleted to 
become an endogeneous DNA element vertically transmitted. The mechanism of insertion of the 
RNA viruses, which normally don’t integrate into the host chromosome in a productive life cycle, is 
generally unknown. But one exception is Bornavirus, as it was found to be catalyzed by the activity 
of LINE-1 retrotransposons that perform a reverse transcription of mRNAs into DNA elements in 
human cells (Horie et al., 2010). However, some other bornavirus elements did not show the 
characteristic features of LINE-1 driven integration activity. Putative functions on host genome of 
these insertions are still undefined, and possible evolutionary roles in host protection against 
related viral infections have been proposed (Chuong et al., 2016; Horie et al., 2010). 
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3. Endogeneous DNA viruses 
Viruses with DNA genomes from different families have also been identified colonizing the germ 
line of plants (Bejarano et al., 1996), vertebrate and invertebrate animals (Arbuckle et al., 2010), 
and human genomes (reviewed in (Katzourakis and Gifford, 2010) ). Most of the identified 
endogenous DNA virus elements correspond to some of the currently known ssDNA virus families 
classified by the ICTV, which are common infectious entities in the three domains of life (Krupovic, 
2013). Indeed most identified endogenous ssDNA virus elements (ESVEs) belong to the 
Parvoviridae (Arriagada and Gifford, 2014; Belyi et al., 2010) (see Table 1). As described above, this 
family of viruses (Cotmore et al., 2014) are common exogenous infectious entities in a wide range 
of vertebrate and invertebrate hosts, including primates and humans. But, in spite of the frequent 
presence of ESVEs in many eukaryotes, the information on primate ESVEs segments is limited to 
an AAV insertion in baboon (Katzourakis and Gifford, 2010)  lacking molecular confirmation, and a 
fragment with far putative relationship to AAV in humans (Liu et al., 2011). 
Table 1. Endogenous Parvovirus Elements (EPEs) in animals. 
Subfamily Genus Host 
Parvovirinae 
Dependoparvovirus 
Bat 
(Pteropus alecto) 
Elephant 
Loxodonta africana 
Dolphin 
(Tursiops truncatus) 
Protoparvovirus 
Rat 
(Rattus norvegicus) 
Guinea pig 
(Cavia porcellus) 
Common brushtail possum 
(Trichosurus vulpécula) 
Amdoparvovirus 
Hyrax 
(Procavia capensis) 
Densovirinae Densovirus 
Green peach aphid 
(Myzus persicae) 
Thorny Stick Insect 
(Aretaon asperrimus) 
Brown marmorated stink bug 
(Halyomorpha halys) 
 
  
 17 
 
 Introduction 
4. Mechanisms of ssDNA parvoviruses integration into host genomes. 
The widespread presence of endogenous genetic elements belonging to parvoviruses in animal 
genomes may be related to the remarkable capacity of some members of this viral family, to be 
inserted in the genome of cells in culture. The Dependoparvovirus adeno-associated virus serotype 
2 (AAV2) exhibits a site-specific insertion mechanism (Berns and Linden, 1995) into chromosome 
19q (Kotin et al., 1992; Samulski et al., 1991), and at other sites (Hüser et al., 2010; Janovitz et al., 
2013) of human cells, which is driven by the activity of the Rep non-structural viral protein.  
 
 
 
 
 
 
 
 
Figure 8.  Dependoparvovirus AAV and insertion in the human genome. 
A: Capsid features of AAV2. The topology of the spike, depression and canyon in the T=1 AAV2 
capsid are illustrated. B: Genomic organization of AAV2, showing the three promoters and the 
distribution of the encoded Rep and Capsid proteins. C:  Drawing of the latent infection of AAV2, in 
the absence of helper, leading to genome insertion in the human chromosome 19. (from Flint et 
al., 2008). 
This unique feature made it an useful vector for several ongoing gene therapy applications 
(Buchholz et al., 2015). However, the capacity and site specificity of AAV seems to drastically differ 
from cultured cells to primary or natural cells. High prevalence of AAV unintegrated sequences are 
common in human tissues (Gao et al., 2004; Schnepp et al., 2005), and high number of infectious 
AAV circulate in monkeys (Gao et al., 2002, 2003). AAV2 may also insert its genome in other 
unrelated sites causing the activation of oncogenes that lead to severe diseases such as 
hepatocellular carcinoma (HCC) in mouse and humans (Donsante et al., 2007; Nault et al., 2015). 
On the other hand AAV5 may require different sequence organizations for its insertion (Janovitz et 
al., 2014), while other parvoviruses may become inserted at certain experimental conditions in cell 
culture (Hendrie et al., 2003). 
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Objectives 
The virus members of the Parvoviridae show wide distribution in nature causing inapparent or 
pathogenic infections in invertebrates and vertebrate animals including humans. Under certain 
interaction conditions they may integrate their genome into that of their host, and the integration 
may be stabilized into germline cells (endogenization). On the other hand, many species of these 
viruses are being extensively exploited as natural vehicles or genetically engineered vectors in 
gene therapy, and anti-cancer clinical trials in animals and humans. Despite these relevant 
biomedical and biotechnological properties, our knowledge on the molecular mechanisms 
mediating parvovirus cellular entry and endogenization in human and non-human primate 
genomes is still very limited. We therefore attempted to provide novel data on these issues 
addressing the following aims: 
1. Extensive analysis of the chemical-physical properties of MVMi capsid, including 
thermostability and genome uncoating, compared with that of the MVMt (mutant) 
exhibiting a remarkably high specific infectivity. 
2. Molecular analysis of the specific infectivity of these viruses (MVMi and MVMt) in the 
context of their entry pathways in human cancer cells. 
3. Bioinformatic screening of primate genomes for the presence of parvovirus endogenous 
elements, confirming (whenever possible) their presence by molecular methods. 
4. Characterization of the sequence and molecular structure of the confirmed endogenous 
primate parvovirus elements. 
  
  
 
 
 
 
 
 
 
 
  
  
Materials 
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Materials and Methods 
1. Cellular studies 
1.1. Cell lines  
The following cell lines were used in this study: 
- NB324K (4K): Kidney fibroblasts of newborn human, transformed by SV40 (Shein and 
Eneders, 1962; Shein et al., 1962). This cell line was kindly provided by B. Hirt, Epalinges, 
Switzerland. 
- U87 MG: Astrocytes of human glioblastoma (ATCC: HTB14) 
- Vero: Kidney epithelial cells of Cercopithecus aethiops (kindly provided by A. Carrascosa, 
CBMSO, Madrid) 
- COS1: Kidney fibroblasts of Cercopithecus aethiops, transformed by SV40 (kindly provided 
by A. Carrascosa, CBMSO, Madrid) 
 
1.2. Cell cultures 
1.2.1. Materials 
Mammalian cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) containing 5% or 
10% of Fetal Calf Serum (FCS). Cells were detached from the plastic petri dish with 25% Trypsin 
(Invitrogen), and stocks with minimal number of passages were preserved frozen in liquid nitrogen 
(see below). Cells were washed in Phosphate buffered saline (PBS), pH: 7.2-7.4, and inoculated 
with viruses in PBS supplemented with Mg++ and Ca++ (PBS++). Cells were routinely maintained in an 
Incubator set at 37°C with 5% CO2 and humidified atmosphere, visually inspected by an inverted 
microscope (Leica Olympus), and the cell numbers were determined in Neubauer chamber (or 
hemocytometer).  
1.2.2. Cell passages. 
In order to provide nutrition, and remove the metabolic toxins, cells were passaged prior reaching 
full confluence. For this, the medium was removed by vacuum, the cell monolayers were washed 
with PBS, and trypsin (800-1000 µl/P100) was added. When significant number of rounded cells 
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was observed under microscope, the excess of Trypsin was removed and the cells were kept in the 
incubator for 1-3 minutes. When cells became completely detached, they were resuspended in the 
corresponding medium and 10 µl of the suspension was taken apart to be counted in Neubauer 
chamber. The required amount of cells for each seeding was calculated and added to each plate 
containing the growth medium. 
1.2.3. Cells preservation. 
In order to have fresh cells, and avoid possible contaminations and extensive passages, each cell 
line was frozen in aliquots in liquid nitrogen until needed.  For this, a plate containing fresh cells 
growing in good conditions was washed with PBS, detached with trypsin as above, and 
resuspended in 2-3 ml of DMEM 10% media. The suspension was moved to a 15ml falcon tube, 
centrifuged at 1200rpm for 5 minutes (Sorvall). The cell pellet was resuspended in 1:1 ratio of a 
cocktail containing M-I medium (DMEM and 20% FCS) and M-II medium (DMEM and 20% FCS and 
30% Glycerol) and it was aliquoted in cryotubes (Nunc). The aliquots were first kept in freezing 
container rack inside the -70°C freezer for at least 24h, afterwards the samples were kept in liquid 
nitrogen (-180°C – 210°C). For further use, frozen cells were incubated at 37 °C in a water bath 
until defrosted, then added to a falcon (F15) tube containing 10 ml of DMEM supplemented with 
5% of FCS and centrifuged 5 min at 1500 rpm (Sorvall). The supernatant was removed, and the 
pellet was resuspended in the corresponding medium and finally seeded in appropriate plates 
(plastic petri dishes).  
1.2.4. Cells infection with viruses. 
One day prior to infection, the cells were seeded usually at a density of 2.5 x 105 cells per P60mm 
petri dish. For infection, cells were washed with PBS, the calculated amount of virus, diluted in 500 
µl (per P60mm) of PBS++ with 0.1% of FCS, was added to the cells. A negative control (Mock), 
containing cells treated with the same amount of buffer but no virus, was considered for each 
experiment. After inoculation, the plates were shaken gently for one hour at 37°C, then the virus 
was removed and fresh medium was added. Assuming this time as zero point of infection (T0), the 
plates were kept at 37 °C inside incubator for the desired time. 
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2. Virus studies 
2.1. Viral strains.  
The Protoparvovirus Minute Virus of Mice (MVM) was used in all the experiments of this study. 
Viral strains were: 
- MVMi (also referred as MVMi-wt), the immunosuppressive strain (Bonnard et al., 1976; Segovia 
et al., 1999) (Kindly provided by B. Hirt, Epalinges, Switzerland) 
- MVMt mutant (also referred as T-Mutant), a Thr/Ala point mutant constructed in the non-
structural (NS) gene of the MVMi genome (Guerra, 2000). 
2.2. Virus Production and Purification 
MVMi wt and mutant viruses were produced and highly purified following previously published 
methods (Gil-Ranedo et al., 2015; Rubio et al., 2001; Santarén et al., 1993) with some 
modifications. Viruses were prepared from their respective molecular clones, pMVMi and pMVMt 
mutant (Guerra, 2000). These plasmids were previously amplified in JC8111 Escherichia coli strain, 
and transfected into NB324K human cells by electroporation. Cells were cultured 48 hours, lysed 
by freezing-thawing and clarified, and the intracellular virus was harvested and kept at -70 °C as 
reference stock. For large scale virus production, NB324K cells seeded in four P100 plates and 
grown to 80% confluence were infected with the reference virus stocks at low MOI (10-3 PFU/cell) 
and kept at 37°C in the incubator. After 7 days, the cells (showing extensive cytopathic effect), 
were scraped in the same medium and centrifuged at 5000 rpm for 15 minutes (4°C). The virus in 
the supernatant was recovered by adding 3.4% Polyethylene glycol (PEG) and 0.5M NaCl followed 
by 24h incubation at 4 °C and then 30 minutes of 5000 rpm centrifugation. The cell pellet was 
resuspended in PBS + 0.1% Sarkosil, dispersed by sonication at 20 kHz (2 min) and finally 
centrifuged at 800 rpm for 10 minute (4°C). The supernatants were next mixed and centrifuged 
through a 20% sucrose cushion+ 0.1% Sarkosil in a TST.28.38 rotor at 18krpm for 16h at 12 °C. 
Virus pellets were resuspended in PBS + 0.1% Sarkosil and subjected to Caesium Chloride (CsCl) 
equilibrium centrifugation adjusted to the density of 1.38 g/ml in a final volume of 10 ml. Samples 
were centrifuged at 50,000 rpm, 24h at 8 °C in a TFT 80.13 rotor. Fractions of 500µl were taken up 
to down into 1.5ml Eppendorf tubes and subjected to the hemagglutination assay (refer to M&M 
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2.3.1). The virus containing fractions (density range from 1.39 to 1.43 g/ml) were pooled and 
rebanded at the same conditions as above, to remove empty capsids. Finally, the fractions of the 
second gradient with hemagglutination activity and density corresponding to DNA-filled virus were 
pooled, and the excess of CsCl was removed by extensive dialysis against PBS. Viral stocks were 
kept in aliquots at -70°C, and maintained at 4°C for routine use within two weeks.  
 
2.3. Virus titration  
In order to have a reliable comparison between viruses, different viral titration methods were 
used. 
2.3.1. Hemagglutination Assay (HA) 
This method was used to determine the amount of virus particles (including DNA-filled virions and 
empty capsids) by their capacity to agglutinate mouse red blood cells. 1ml of heparinized mouse 
fresh blood was taken to 10ml in PBS (10 times of the blood volume) on ice and washed by 
centrifugation at 2000 rpm for 5 minutes and re-suspension in 10 ml of PBS (three times).  A 96U 
well plate was filled with 50 µl of PBS in each well (98µl in the first row), then 2µl of capsid or virus 
sample (sample volume) was added to the first row (final volume 100 µl). Serial ½ dilutions starting 
with 50µl of the first row were made and 50µl excess of the last dilution was removed. Then 50µl 
of 1% recently washed red blood cells was added to each well and the plate was kept at 4°C for at 
least two hours. Finally, the hemagglutinated wells were counted (n) and viral particles were 
determined as hemagglutination units per each ml according to the following formula:   
𝐻𝑒𝑚𝑎𝑔𝑔𝑙𝑢𝑡𝑖𝑛𝑎𝑡𝑖𝑛𝑔 𝑢𝑛𝑖𝑡𝑠 (𝐻𝐴𝑈) =
 2𝑛
𝑆𝑎𝑚𝑝𝑙𝑒 𝑣𝑜𝑙𝑢𝑚𝑒
 
2.3.2. Real Time PCR 
This method was used to measure the amount of viral DNA by specific MVM primers (Ros et al., 
2006). It was set up and carried out during the short stay under supervision of Dr. Carlos Ros 
(Department of Chemistry and Biochemistry, University of Bern, Switzerland).  
The standard DNA quantity was prepared by MVM-plasmid with known concentration (previously 
measured by A260 absorbance). Different dilutions of standard were made to normalize the 
measurement, and viral concentration was measured according to the standard. 
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The master mix was prepared as shown in Table 2. Then, 2 µl of DNA including various virus 
dilutions (10-1, 10-2, 10-3 and 10-4) or standard dilutions (10-7, 10-6, 10-5 and 10-4) were added to 18 
µl of master mix. The PCR program (Table 3) was run on CFX96 (BioRad) and the viral amounts 
were estimated using the CFX Manager™ software. 
Table 2. Components used for each reaction of Real Time PCR 
 
 
 
 
 
Table 3. PCR program applied to quantify MVM DNA copies 
Initial denaturation 95°C 300 s 
 
Denaturation 
95°C 15 s 
61°C 15 s 
72°C 15 s 
 
40 cycles 
Annealing 
Extension 
Final denaturation 95°C 60 s 
 
Melting curve 65°C up to 95°C 0.1°C/s 
 
 
2.3.3. Electron Microscopy 
The number of viral particles was also determined by a transmission electron microscope [JEOL 
(JEM1010)] operating from 12k to 100k magnitude. In order to visualize the viral particles, the 
negative staining with Uranyl Acetate was applied on 1- 10 µl of viral serial dilutions.  After the 
ionization, the copper grids were put on the samples (facing the samples) for 3 minutes, then 
washed 3 times in ddH2O (facing the water) and kept on Uranyl Acetate less than 1 minute. Then 
samples were dried on filter paper for 5 minutes and eventually observed at 12k, 40k and 60k of 
magnitude. The amount of virus particles in 12K magnitude was counted and used for relative 
study of particles in viral stocks.  
Component Details Vol. (µl) Final Con. 
iTaq Supermix (2X) Bio-Rad 10 1X 
Primer Forward (10pM) 5’-GACGCACAGAAAGAGAGTAACCAA-3’ 1 0.5 pM 
Primer Reverse(10pM) 5’-CCAACCATCTGCTCCAGTAAACAT-3’ 1 0.5 pM 
ddH2O DNase- RNase free Gibco 6 
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2.3.4. Infectivity Methods. 
2.3.4.1. Plaque Assay (PA) 
This assay was used to measure the number of viral particles that can form plaques in semi-solid 
medium. First, cells seeded on P60 or P35 dishes (the day before) were infected with various 
dilutions (e.g. 10-2, 10-3, 10-4 and etc.) of virus in 500µl of PBS++ (in case of P60 plates) for one hour 
at 37 °C. The virus inoculum was removed and a total of 7 ml of semi-solid medium 
(DMEM+antibiotics, 10% FCS, 0,8 % Agarose FMC SeaPlaqueTM) was added to each P60 plate. The 
plates were kept at 4°C for 5 minutes until the gel of Agarose was formed, and then placed at 37°C 
in the incubator. After 6 days, cells were fixed by adding 10% Formaldehyde (for at least 2 hours), 
stained with 0.2% Cristal Violet in 10% Formaldehyde (1 hour), and finally washed with ddH2O and 
dried. The number of plaque forming units was routinely determined in triplicates. 
  An example with serial dilutions is shown. The plaques were counted and then the concentration 
of Plaque Forming Unit (PFU)/ml was calculated according to the following formula 
 D= dilution and V= Volume 
 
𝑃𝐹𝑈
𝑚𝑙
=
Number of Plaques
D x V
 
 
 
 
 
 
 
2.3.4.2. Colony Forming Assay (CFA) 
The CFA was used to study cell survival after infection (based on Ramírez et al., 1995). Two days 
prior to the experiments, cells were seeded in P60 plates to obtain 80% confluence. In the day of 
infection, cells were washed with PBS, then Trypsin was added for 2 minutes and immediately 
stopped with serum containing medium. The detached cells were collected and centrifuged at 
2500rpm for 5 minutes, resuspended in 10ml of FCS containing medium, and then incubated at 
37°C incubator (to regenerate the receptors). After 1 hour the cells were centrifuged at 2500rpm 
10-1 10-2 Mock 
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for 5 minutes, resuspended in 1ml of medium, and the number of cells was counted in the 
hemocytometer (Neubauer chamber). For each infection, 105 cells were added to 1.5 ml 
Eppendorf tubes, serial amounts of virus were added to the cells (in 50µl of volume per each 
infection) and the infection was incubated at 37°C in a Thermomixer (Eppendorf). After one hour 
the cells were seeded in a serial dilution of 104, 103and 102 cells/P60 dish and kept at 37°C in the 
incubator. After 6 hours a neutralizing anti-MVM antiserum was added to stop putative virus 
progression. After 10 days, the medium was removed, cells were washed with PBS, fixed with 4% 
formaldehyde (60-120 minutes), stained with Cristal Violet (1 hour), and washed with ddH2O. 
Finally, the cell colonies were counted and the number of survived cells/ml was estimated and 
used for relative study between both viruses (see illustrative example below). 
 
 
 
  
2.4. Analysis of in vivo 32P-radiolabeled capsid proteins. 
32P-labeled capsid subunits of MVM were produced and purified in NB324K cells following a 
previously described method (Gil-Ranedo et al., 2018; Maroto et al., 2000, 2004) with some 
modifications. Cells were infected at MOI 10, starved for 4 hours in phosphate-free DMEM 
supplemented with 5 % dialyzed FCS, and labeled from 4 to 24 hpi in the same medium containing 
0.1 mCi per ml of [32P] orthophosphate carrier free (Perkinelmer). Cells were washed and scraped 
into PBS supplemented with 0.2 % sodium dodecyl sulfate (SDS), protease inhibitors (1mM 
phenylmethylsulfonyl fluoride (PMSF); 10 µg/ml aprotinin; 10 µg/ml pepstatin; 10 µg/ml 
leupeptine) and phosphatase inhibitors (5 mM NaF, 20 mM β-glycerophosphate). The 
homogenates were boiled to disassemble capsids and denature VPs proteins, cooled to 4 °C, and 
debris were removed by low speed centrifugation (10,000 x g, 15 min). The supernatants were 
collected avoiding pellet contamination, and anti-VPs antibody (1/200) was added and incubated 
at 4 °C overnight under gentle rotation. Homogenates were next incubated with 10% protein A-
sepharose equilibrated in binding buffer (BF: 50mM Tris-ClH, pH 7,5; 150 mM NaCl; 1mM EDTA, 
1% NP-40, 0.1 %BSA) for 2h under shaking at 4 °C, and the immune-complexes were finally 
10-1 10-2 Mock 
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recovered by low speed centrifugation (10,000 x g, 10 min). Pellets were washed 
(resuspension/incubation at 4 °C in BF/centrifugation) twice more before elution by boiling in 
Laemmli buffer at 95 °C for ten minutes. The 32P-radiolabled VPs proteins were resolved by SDS-
PAGE and visualized by autoradiography.  
 
2.5. Enzymatic analysis of virus phosphorylation 
Highly purified viral particles were subjected to a concentration gradient of lambda phosphatase 
enzyme (NE Biolabs). The reactions were prepared according to manufacturer’s guide and also as 
described by Wolfisberg et al., 2016.  
3. Cellular analyses 
Different types of microscopes were used to visualize the virus particles, or virus interaction with 
cells (Table 4).  
Table 4. Microscopes used in this study 
Type Device Name Manufacturer Labeling 
Florescent 
Microscope 
Axiovert Zeiss FITC, Texas Red, DAPI 
CCD chamber Zeiss FITC, Texas Red, CY5, DAPI 
Multiphoton Confocal Zeiss FITC, Texas Red, CY5, DAPI 
 (TEM) Electron Microscope JEOL (JEM1010)] Uranyl Acetate contrast  
 
3.1. Immunofluorescence  
3.1.1. Slide preparation 
The round glass cover slips were submerged in ethanol 100% for 10 minutes. In each P60 plate, 6 
cover glasses were adhered and dried under sterile air flow, the calculated amount of cells was 
seeded in each P60 plate, then incubated at 37 °C in the incubator. When the cells were 80% 
confluent the infection was performed (refer to M&M: 1.2.4.), afterwards the cells were washed 
with 2ml of PBS and fixed by 3ml of 4% Paraformaldehyde (PFA) for 8 minutes. The PFA was 
replaced with 3ml of PBS and the plates were kept at 4 °C until staining. 
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3.1.2. Fluorescent antibody staining 
Each coverslip was taken to individual well of a M24 plate previously filled with PBS. Then the PBS 
was replaced by permeabilization buffer containing 500 µl of PBS and 0.1% Triton X-100, and 
samples were shaken gently for 10 minutes on rotator. The permeabilization buffer was replaced 
by 500 µl of PBS+0.1% Triton X-100 containing 1% FCS (blocking solution) for 20 minutes. After 
blocking, a 10 cm x 10cm Parafilm was placed on a filter paper in a humid box, and 25 µl of 
primary antibody was placed on Parafilm for each coverslip (see table 5 for dilutions). Covers were 
kept on Parafilm facing toward the antibody for 1 hour at 37 °C, then moved to a P24-dish (facing 
up) and washed 4 times with PBS (5 minutes on rotator each time). Then, the secondary antibody 
was applied in the same way as primary antibody, and samples were incubated at 37°C for 45-60 
minutes. Eventually, the secondary antibody was washed by submerging the cover glasses 20 
times in PBS and 2 times in ddH2O. Finally, 10 µl of MOVIOL+DAPI (Fluoromount) was placed on 
microscope slide and the coverslips were mounted on the slides placing the cells facing toward the 
Fluoromount. Slides were dried for 20 hours at room temperature, or 1 hour at 37 °C, and then 
kept at 4 °C until microscopic analysis. 
Table 5. Antibody dilutions used for Immunofluorescence  
Name Source Description Type 
Working 
dilution 
Fluorophor 
emission 
Anti-NS1 Rabbit 
Non-structural NS1 
protein of MVM 
Primary 1/100 
 
Anti-Vps Rabbit 
denatured MVM capsid 
proteins 
Primary 1/200 
 
Anti-B7 
Mouse 
(Mab) 
B7 epitope of MVM 3x 
Capsid 
Primary 1/50 
 
Anti- MVM 
Capsid 
Rabbit Entire Capsid Primary 1/200 
 
Anti Rabbit Goat FITC Secondary 1/500 488nm 
Anti Mouse Goat Texas-Red Secondary 1/500 564nm 
 
  
3.1.3. Fluorescent DNA in situ hybridization (FISH) 
Cells fixed with PFA were permeabilized for 10 minutes by 500µl of PBS + 0.2% Triton X-100, then 
the samples were equilibrated with Saline-Sodium Citrate (SSC) 2X + 15% Formamide for 5 
minutes. A humid box was prepared and then 10 ng of each oligo (labeled with CY5-alexa 647 nm) 
in 50 µl of FISH buffer (Gil-Ranedo et al., 2015) was spotted on coverslips. Samples were incubated 
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in humid box at 37°C for 3 hours and finally washed 2 times with SSC 2X + 15% Formamide for 20 
minutes at 37 °C.  This method was generally followed by antibody staining, and observation under 
fluorescence microscopy (refer to M&M: 3.1.2). 
4. Molecular analyses 
4.1. Nucleic acids Extraction 
4.1.1. Virus DNA extraction 
The DNeasy Blood & Tissue Kit (Qiagen) was used, following the manufacturer's protocol, to 
extract the viral DNA to be used for real time PCR.  
4.1.2. Tissue DNA extraction 
Frozen tissue samples were sliced, and per each 10 g wet weight 700 µl of 50mM Tris-HCl (pH:8), 
100mM EDTA (pH:8), 100mM NaCl and 1% SDS was added. The slides were incubated at 55 °C 
overnight with 18 µl of Proteinase K (20 mg/ml), then 4 µl of RNase A+T1 (Qiagen) was added and 
samples were incubated 30 minutes at room temperature. Afterwards, 250 µl of saturated NaCl 
(more than 5M) was added to samples, shaken, and then centrifuged at 14000 rpm for 5 minutes. 
500µl of Isopropanol 100% was added to 850µl of supernatant, mixed well and centrifuged at 
12000rpm for 5 minutes. The pellet was washed with 500-1000 µl of 75% Ethanol at 4 °C, 
centrifuged at 12000 rpm for 3 minutes in the cold room and air dried. Finally, the DNA was 
resuspended in 100µl of TE buffer (10mM Tris-HCl, 1 mM EDTA, pH 8). 
4.2. Amplification of genetic material  
4.2.1. Primer Design 
The genomic DNA sequences were obtained from GenBank (www.ncbi.com/genbank). The 
Generunner software (Ver. 05.0.63) was used to select the best oligos according to their GC 
content, annealing temperature, secondary structures and interactions with other oligos. The 
probability of non-specific amplification was checked by BLAST (www.ncbi.com/BLAST). 
4.2.2. Polymerase Chain Reaction (PCR) 
Each DNA sample was amplified in a 25µl of PCR reaction (Table 6) using different annealing 
temperatures according to the primers (please refer to M&M: 4.2.1). The amplified fragments 
were loaded on Agarose gel in Tris Acetate EDTA buffer (TAE) buffer stained with Ethidium 
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bromide (EtBr). In case of sequencing or cloning, the fragments were cut from gel and purified 
with Promega Wizard® SV Gel and PCR Clean-Up kit following to the manufacturer’s guide. DNA 
sequencing service was provided by Scientific Park of Madrid (Parque Científico de Madrid). 
Table 6. PCR components 
Component 1 Reaction (25µl) Final Concentration 
10X Biotools Colorless buffer 2.5 µl 1X 
MgCl2 (50mM) 1.5µl 3mM 
dNTP mix (10mM) 0.5µl 0.2mM 
Primer Sense (diluted 1/10, 10µM) 1.25µl 1 µM (0.05–1 µM) 
Primer Antisense (diluted 1/10, 5µM) 1.25µl 1 µM (0.05–1 µM) 
Go TaqDNApol (5u/µl) 0.25 1.25 U 
H2O Up to 25   
DNA (100ng/µl) 1-5 µl   
 
4.3. Southern blot 
This method was used to study the presence of specific viral DNA sequences in genomic samples. 
The experiment was performed following the procedures previously described (Gil-Ranedo et al., 
2015; Ramírez et al., 1996). Briefly, the restricted DNA samples were resolved in 1%-agarose gels, 
alkali-blotted to nylon membranes (GeneScreen) and filters were hybridized at high stringency 
with a AAV2 (Hamilton et al., 2004) or MVM full-length probes 32P-labeled by random priming with 
α-32P- dCTP (Perkinelmer). 
4.4. Western blot 
Infected cells were washed with PBS and homogenized in Laemmli buffer (1.2x Concentration). 
Extracts were incubated at 100°C for 10 min. Protein resolution was performed in denaturing 
conditions (SDS-PAGE) electrophoresis by 8% Acrylamide:Bisacrylamide gels. The resolved proteins 
were transferred to Nitrocellulose membrane (0.45m pore) in humid conditions at constant 
voltage (100V) for 55min. Detection of proteins in the transferred membrane was made according 
to standard protocol using Tris-Buffered Saline containing 0.1% Tween20 (TBS-T) for washing 
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steps, TBS-T + 10% FCS for blocking step and TBS-T + 1% FCS + 1% NP40 for antibody incubations. 
Table 7 shows the concentration of antibodies that were used in this experiment (see table). 
Secondary antibodies, -Rabbit-HRP (horseradish peroxidase) (Jackson ImmunoResearch) and -
Mouse-POD (peroxidase) (Jackson ImmunoResearch), were used in a constant concentration of 
1/10000. ThermoFisher Scientific product “SuperSignal West Pico PLUS Substrate” was used to 
develop the cheminiluminiscence assay to be exposed on X-ray films. Finally, the X-ray films were 
scanned using Densitometer GS900 BioRad and lane quantification analyses were done using the 
“Image Lab BioRad” Software.   
Table 7. Antibodies used for western blot  
Antibodies Concentration Source 
Anti-VPs 1/4000 Rabbit 
Anti-VPsVBK * 1/2000 Rabbit 
*Anti-VPsVBK is a purified version of Anti-VPs 
4.5. Analysis of viral particles configuration by agarose-blot  
An innovative method was set up in order to detect viral particles in their native/denatured state 
by agarose electrophoresis and blotting to nitrocellulose membranes.  
4.5.1. Resolution of viral particles by agarose electrophoresis and blots 
Virus samples were prepared in PBS supplemented with 15% glycerol on ice. In case of cell 
extracts, the extracts were supplied with protease inhibitors (0.1mM phenylmethylsulfonyl 
fluoride, 10µg/ml Leupeptin, 10µg/ml Pepstatin, 10µg/ml aprotinin and 10µg/ml TPCK) and 0.1% 
Triton in order to remove any innate cellular protease activity (Gil-Ranedo et al., 2015). Samples 
were loaded in precooled 1.2 % agarose gel at 4 °C prepared in Tris Acetate EDTA (TAE) buffer. The 
electrophoresis was performed at 4 °C in the same buffer running for two hours at 80V. Next a 
capillary-blot was performed at room temperature to transfer the virus samples to nitrocellulose 
membranes. For this, a saline-sodium citrate SSC-10X (1.5M NaCl, 0.15M trisodium citrate) and 10 
mM Tris pH 7.5 buffer were used. The agarose gel was placed upon Watman filter, subsequently 
the nitrocellulose membrane was placed on the top of the gel with two other Watman filters upon 
it, and finally a stack of filter papers was placed on top of all. Blot was allowed to proceed 
overnight, and then the nitrocellulose filter was placed on filter paper wet with Tris Buffer Saline 
(TBS) for 10 minutes at room temperature. 
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 4.5.2. Analysis of native viral particles resolved by agarose blots. 
Filters were soaked in blocking buffer containing TBS (50mM Tris-HCl pH:7.5 and 150mM NaCl), 
10% FCS and 0.1% tween for 1- 2 hours. Then three steps of washing with TBS-T (TBS+ 0.1% 
tween) were performed, and the membrane was incubated with the primary antibody in TBS-T 
supplemented with 1% FCS and 1% NP-40 at 4 °C overnight. Afterwards another three steps of 
washing at 4 °C were performed and a Horseradish Peroxidase (HRP) secondary antibody (diluted 
in the same buffer as the primary antibody) was added for 1 hour. Finally, the membrane was 
washed three times in TBS+ 0.1% tween and once in TBS for 15 minutes and developed by 
enhanced chemiluminescence (ECL) buffer (Amersham) for 5 minutes. The luminiscence signal was 
revealed on autoradiography films after several times of exposure. 
4.5.3. Analysis of capsid subunits of viral particles by agarose-blots 
This method was set up to detect the unassembled capsid subunits irrespective of viral particle 
configuration. After the overnight blot, the membrane soaked in TBS was placed at 78 °C in an 
oven for 2 hours. Then it was placed in humid chamber onto a filter paper that contains the 
solution of TBS + SDS 1%, at 37 °C for 15-20 minutes. These treatments were on purpose to fully 
denature viral capsids and their protein subunits. Afterwards, the same protocol as native blot was 
applied to develop the membrane with antibodies, but normally the primary antibody was the 
anti-VPs (polyclonal) recognizing mainly denatured capsid proteins. Table 8, outlines the 
antibodies used for native or denatured structures of viral proteins resolved by agarose blots. 
Table 8. Antibodies and dilutions used for the agarose blot method 
Name Type Description Source Dilution 
Anti VPs Primary Denatured condition Rabbit 1/5000 
Anti B7 Primary Native condition Mouse 1/2000 
Anti-Capsid Primary Native condition Rabbit 1/4000 
Anti-Mouse HRP Secondary HRP(Thermofisher) Goat 1/10000 
Anti-Rabbit HRP Secondary HRP(Thermofisher) Goat 1/10000 
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5. Bioinformatic studies 
Comprehensive search for endogenous parvoviral elements was initially performed using eight 
representative members of Parvoviridae (MVM, AAV2, BPV, PBoV4-1, B19, PARV-4, AMDV-G and 
GmDNV) against a total of thirty two genomes belonging to human and non-human primates 
(Table 9), which are currently available in refseq_genomics and whole genome shotgun (wgs) 
databases. After obtaining the initial molecular results by representative members of Parvoviridae, 
the seach was extended to all the members of the family (Table 10). Different softwares were used 
to identify the corresponding DNA sequences of Parvoviridae in Primates as explained below. 
Table 9. Haplorhini Suborder list of species tested  
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Table 10. ssDNA viral references used for the screening of EVE in primates genomes 
Genus Species Strain Acronym Accession # 
Ambidensovirus 
Lepidopteran 
ambidensovirus 1 
Galleria mellonella 
densovirus 
GmDV L32896 
Amdoparvovirus Carnivore amdoparvovirus 1 Aleutian mink disease virus AMDV M20036 
Bocaparvovirus 
 
Ungulate bocaparvovirus 1 Bovine parvovirus BPV M14363 
Ungulate bocaparvovirus 5 Porcine bocavirus 4-1 PBoV4-1 JF429835 
Dependoparvovirus 
Adeno-associated 
dependoparvovirus A 
Adeno-associated virus - 2 AAV2 AF043303 
Adeno-associated virus - 7 AAV7 AF513851 
Adeno-associated virus - 8 AAV8 AF513852 
Adeno-associated 
dependoparvovirus B 
Adeno-associated virus - 5 AAV5 AF085716 
Anseriform 
dependoparvovirus 1 
Goose parvovirus GPV U25749 
Anseriform 
dependoparvovirus 1 
Muscovy duck parvovirus MDPV U22967 
Avian dependoparvovirus 1 
Avian adeno-associated 
virus strain DA-1 
AAAV AY629583 
Beared Dragon 
dependoparvovirus 
Bearded dragon parvovirus BDPV KP733794 
Caprine Adeno-associated 
virus 1 
Adeno-associated virus-
Go.1 
AAV-Go.1 DQ335246 
Chiropteran 
dependoparvovirus 1 
Bat adeno-associated virus 
YNM (BtAAV) 
BtAAV GU226971 
Squamate 
dependoparvovirus 
Snake adeno-associated 
virus 
SAAV AY349010 
Erythroparvovirus Primate erythroparvovirus 1 
Human parvovirus B19 
isolate J35 
B19V-J35 AY386330 
Protoparvovirus Rodent protoparvovirus 1 Minute virus of mice MVM J02275 
Tetraparvovirus Primate tetraparvovirus 1 Human parvovirus 4 G1 PARV4G1 AY622943 
 
5.1. NCBI 
The National Center for Biotechnology Information (NCBI) website 
(https://www.ncbi.nlm.nih.gov/) was used for various studies as follows:  
5.1.1. GenBank 
This database (https://www.ncbi.nlm.nih.gov/genbank/) was used to find the complete genome 
sequences of annotated  Parvoviruses as well as primates. 
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5.1.2. BLAST 
The Basic Local Alignment Search Tool (BLAST) application is an online alignment software 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) which was used for comparison of nucleotide sequence 
against other nucleotide sequence (BLASTn), protein sequence against nucleotide sequence 
(tBLASTn), protein sequence against protein (BLASTp) and nucleotide sequence against protein 
sequence (BLASTx) (Altschul et al., 1990; Belshaw and Katzourakis, 2005; States and Gish, 1994). It 
was also used to check the specificity of designed primers (refer to M&M: 4.2.1). In case of 
screening, all searches maintained default parameters being suggested by the program. In order to 
evaluate the significance level of results, a threshold of <1e-10 was set for the E-value associated 
to the alignment obtained by subject (host) sequence.  
5.2. Multiple sequence alignments and phylogenetic analysis 
 The identified SDEs were aligned along with representative members of correspoding parvovirus 
sequence using ClustalW (version 2.1) and Jalview (version 2.8.2) programs (Clamp et al., 2004; 
Sievers and Higgins, 2014). The maximum likelihood phylogenetic tree (Saitou and Nei, 1987) was 
generated by the MEGA version 7.0.14 software package (Tamura et al., 2013) using the Tanimura-
Nei model with 1,000 bootstraps, in order to assess the robustness of the interior branches of the 
tree (Guindon and Gascuel, 2003).                                                                
5.3. Gene Runner 
This offline software (Gene Runner version 5.0. 63 beta) was used to design primers and study the 
interaction of oligos. It was also used to translate the nucleotides to amino acids and find the 
adequate restriction enzyme to cut the desired sites of a genome. 
5.4. RepeatMasker 
This online program (http://www.repeatmasker.org/) was used to identify known repeated 
sequences inside of an unknown sequence (Tarailo-Graovac and Chen, 2009). It was used to 
distinguish the flanking repeated sequences that surround the endogenous parvovirus sequence 
inside the primate genome.  
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5.5. European Nucleotide Archive (ENA) 
Sequences obtained by this study were submitted to this database belonging to EMBL (European 
Molecular Biology Laboratory) by the following link: https://www.ebi.ac.uk/ena 
 
  
 
  
Results 
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Results 
Section A: Post-translational modifications of Parvovirus MVM capsid and 
cell entry.  
1. Virus Titration and specific infectivity of MVMi and MVMt. 
Various conventional methods were used to titrate virus as physical particles and infectious units 
(refer to M&M: 2.3). In these determinations different viral units per milliliters were obtained such 
as Plaque Forming Unit (PFU), Hemagglutination Unit (HAU), and genomic DNA copy number 
(DNA). Moreover, the number of particles per each field at 12K magnitude obtained by 
transmission electron microscope (12k-TEM) was used to study physical differences between 
viruses. Various stocks of viruses were used along this study from independent infections of 
NB324K host cells by MVMi and MVMt viruses, and the virus yields were purified by density 
gradients as described (refer to M&M 2.2). The obtained purified stocks showed different 
concentration of viral particles and infectious units (Table 11). A ratio was applied between the 
different methods of titration for each stock.  
Table 11. Purified stocks of MVMi and MVMt viruses used in this study. 
Stock Label Extraction date PFU/ml HAU/ml DNA/ml 12k-TEM 
MVMi-I July/2014 1.63E+07 1.70E+04 3.45E+09   
MVMi-II Sep/2014 2.18E+09 1.02E+06 1.25E+11 1.41E+03 
MVMi-III Nov/2015 6.00E+08 1.25E+05   2.34E+02 
MVMi-IV May/2017 1.50E+09       
MVMi-V Jul/2017 1.83E+07 1.28E+04     
MVMt-I Apr/2012 1.00E+11 5.12E+05 2.84E+10 8.72E+02 
MVMt-II Dec/2014 1.51E+09 2.65E+03 4.47E+08   
MVMt-III Jul/2017 1.07E+09 6.40E+03     
Titers are indicated by the different methods used: Plaque assay (PFU), Hemagglutination (HAU), 
Real time PCR (DNA), Transmission electron microscopy at 12K magnitude (12K-TEM) *MVMi-III 
has undergone two rounds of CsCl equilibrium centrifugation. MVMi-V is MVMi-IV subjected to an 
additional round of centrifugation in CsCl and MVMt-II and MVMt-III are rebanded from MVMt-I. 
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2. Specific infectivity of virus stocks. 
The specific infectivity was measured by dividing the infectious determinations (PFU) versus the 
methods determining physical particles (HAU, DNA and 12k-TEM). Figure 9 contains column 
graphs showing the specific infectivity that was obtained by each method. These studies of specific 
infectivity were performed with all stocks and several times per method.  As shown in the figure, 
the MVMt revealed higher ability to infect than MVMi (almost 2 Log10) in all the studies. Thus, 
specific infectivity of MVMt was between 55 to 316 times higher than MVMi, which means that 
less particles of MVMt are needed to form a lysis plaque. These data demonstrated the high 
efficiency of MVMt infection for further implications. 
 
 
 
 
 
Figure 9. Specific infectivity of viral stocks. 
The results were measured by different methods and are shown as Log10. As illustrated in the 
figure the MVMt shows almost 2 Logs more specific infectivity per particle than MVMi. 
 
3. Analysis of MVMi and MVMt responses to heat. 
To search for physical differences between the MVMi and MVMt, highly purified virus particles 
and capsids were subjected to heat treatments. Their integrity, configuration, and genome 
uncoating were determined by different methods mentioned below.  
3.1. Study of MVM physical particles in response to heat by TEM 
The thermostability of the viruses was visualized by TEM (refer to M&M: 2.3.3). The number of 
particles was estimated and their structural integrity was inspected. 
3.1.1. Visualization of the Integrity of the MVM particles 
In order to study the integrity of viral particles, highly purified empty capsids and DNA-filled 
viruses of MVMi and MVMt were subjected to negative staining with Uranyl Acetate. Figure 10 
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shows 100k magnitude of preparations obtained by TEM. It can be clearly observed that in MVMi 
empty capsid samples the stain penetrated inside the particles (positive staining), while both wild 
type and mutant DNA-filled virus particles remained unstained (designated as negative staining). 
 
 
 
 
 
Figure 10.  Visualization of MVM particles by TEM. 
MVMi capsid, MVMi full virus and MVMt full virus were applied on grids and next subjected to 
negative staining by Uranyl Acetate. Grids were inspected by JEOL (JEM1010) and images were 
taken at 100k magnitude. The presence of stain inside the particles is evident only in empty 
capsids. 
 
3.1.2. Analysis of MVM viruses thermostability 
The first analysis seeking biophysical differences between the MVMi and the MVMt was addressed 
measuring their integrity by TEM in response to heat. For this, equal amounts (HAU) of MVMi and 
MVMt purified virions were incubated in water bath, for 10 minutes, at temperatures 55°C, 65°C, 
70°C, 75°C, 80°C, and 85°C, then immediately placed on ice. One sample of each virus was kept on 
ice (4 °C) as control. Samples were applied on grids and stained within one hour post-treatment. 
Under TEM, the number of viral particles were counted per each field at 30k magnitude, using two 
grids per sample. The number and the staining of particles were captured at different 
temperatures and summarized in Figure 11.  
 The electron micrographs of each virus (Figure 11A) illustrate the increase in the proportion of 
stained particles as the temperature raised. This correlation indicates that empty capsids, or 
damaged particles permissive to inside staining are generated by heat. Although the original 
stocks of MVMt and MVMi had a similar low proportion of stained particles when handled at 4 °C 
(presumably contaminant of empty capsids), the proportion of stained particles is higher for MVMi 
than for the MVMt as the temperature was raised. For instance, at 80 °C there is no MVMt, but 
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MVMi harbors countable particles that are mostly stained (65% of all particles) suggesting that the 
structure of MVMi has more thermostability although  particles are  emptied or damaged.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. TEM analysis of the MVMi and MVMt thermostability. 
 A: Electron micrographs (30K magnitude, obtained by TEM) of heat-treated viruses obtained at 
the indicated temperatures. The graphs to the right show the ratio of stained (presumed emptied 
or damaged viral particles) versus total viral particles at each temperature obtained in the 
micrographs. B: Graph showing the percentage of unstained particles (presumably intact virions) 
at each temperature.  
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Figure 11.B shows a representation of the unstained MVMi and MVMt physical particles (intact 
virus) behavior during heat treatment. The number of intact viral particles remained similar across 
low temperatures up to 75 °C, but at 80 °C a drastic difference was noticed between the two 
viruses: at this temperature a high proportion of MVMi viral particles remained countable, 
whereas most MVMt virions were not apparent as physical particles. At the higher temperature 
(85°C) both virions were essentially undetectable. This first analysis showed a clear difference in 
the physical resistance of the MVMi and MVMt viral particles to heat. The tolerance to stain 
penetration inside the virions as well as the preservation of the particles integrity drastically 
differed between the viruses. 
3.2. Hemagglutination analysis of virus capsid configuration in response to heat. 
The capacity of some viruses to agglutinate red cells (hemagglutination, HA) is mediated by a 
regular interaction of surface capsid domains with the erythrocyte membrane. This property, 
which is normally used to determine the amounts of parvovirus particles in viral stocks or virus like 
particles (VLPs) preparations (Hernando et al., 2000; Jin et al., 2016), was used here to study the 
changes in the capsid domain(s) triggering HA of the MVMi and MVMt in response to heat. 
Although the precise amino acid sequence conforming the HA domain has not been determined 
for MVM capsid, this information is available for a small domain conformed at the surface of the 
highly related CPV capsid (Chang et al., 1992), suggesting that heated MVM capsids failing to HA 
may have altered the configuration of some surface domains.  
Identical volumes and concentration (HA units) of highly purified MVMi and MVMt DNA-filled virus 
and empty native capsids were heated in PBS for 10 min at temperatures indicated in Figure 12, 
cold down immediately on ice, and subjected to a conventional HA assay with mouse erythrocytes. 
As shown in the figure, both viruses were essentially HA competent at moderate temperatures up 
to 65 °C. At 70 °C the HA activity decayed similarly in both viruses and for both types of particles, 
suggesting that the packaged viral genome does not contribute to stabilize the capsid in this assay. 
At 75 °C a remarkable fraction of MVMi empty and full viral particles remained HA competent, 
whereas the MVMt particles lost all HA capacity. No HA was detectable at 80 °C for any of the four 
types of particles assayed. Therefore, the configuration of the HA domains on the MVMi capsid 
tolerates heat at higher temperature than the MVMt domain(s) does, a property not detected by 
EM visual inspection.  
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Figure 12. Heat effect on MVM capsid and virus HA capacity.  
Highly purified full virus and empty capsids of MVMi and MVMt were diluted to 0.5ml of PBS at 
4°C. Aliquots of 75µl of each sample were subjected to the indicated temperatures (4°C, 55°C, 
65°C, 70°C, 75°C and 80°C) for 10 minutes. A total of 50 µl of each aliquot was used for serial 
dilution in a conventional hemagglutination assay with 1% mouse erythrocytes overnight. The 
assay was performed in triplicate, and the remaining HA activity was recorded.  
 
3.3. Heat effect on MVM particles assessed by their behavior in agarose electrophoresis  
In order to visualize the integrity and configuration of intact MVM viral particles, a method based 
on the resolution of viral particles by their electrophoretic mobility in agarose gels and subsequent 
detection by western-blotting to membranes was developed.  
3.3.1. Setting-up the method  
The reliability of the method was firstly evaluated using viral particles resolved in 1.2% agarose 
gels at 4 °C and blotted overnight to nitrocellulose membranes. Blotted particles were then 
stained with specific antibodies to determine the preservation of capsid configuration and 
integrity. For this, an antibody raised against denatured MVM capsid proteins (α-VPs), and a 
monoclonal antibody (α-B7) recognizing an epitope configured in intact capsids, were used under 
denaturing and native conditions respectively (refer to M&M: 4.5). Figure 13A shows a 
representative result of this initial test in which MVMi and MVMt empty capsids (C) or DNA-filled 
viruses (V), blotted to membranes, were developed with these antibodies. A number of 
conclusions can be drawn:  
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I) The α-VPs antibody reacts with the structural proteins of denatured as well as intact viral 
particles. 
II) Denatured VPs proteins move faster than intact viral particles, and at a common position in gels 
regardless their origin (MVMi or MVMt, as well as empty or full virus). 
III) Intact capsids of both viruses can be quantitatively detected with the α-B7 antibody, but not if 
viral particles were previously denatured with SDS and heat. Therefore, the configuration of viral 
capsids tolerates the agarose-electrophoresis as well as the blot procedure.  
IV) In native conditions, the MVMi full virus as well as empty capsid runs faster than corresponding 
particles of MVMt. This difference is lost when viral particles were heat-disassembled. 
V) In the native state of both viruses (PBS, 4°C), full viral particles (V) have a heterogeneous 
pattern not observed in empty capsids. 
VI) Full viral particles (V) run faster in gels than empty capsids (C) do. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Setting-up the agarose-blot method for MVM particles.  
 A: Resolution of viral particles under denaturing and non-denaturing conditions. MVMi capsid (Ci), 
MVMi virus (Vi), MVMt capsid (Ct) and MVMt virus (Vt) were prepared in denaturing (5% SDS 
heated at 95°C) and non-denaturing (PBS at 4°C) conditions, and subjected to two hours of 
electrophoresis (80 volts) in 1.2% agarose gel. Samples were capillary-blotted overnight to 
nitrocellulose and stained with the indicated antibodies. A representative experiment of two is 
shown. B: Quantitative detection of MVM particles by the agarose blot method. The indicated 
hemagglutination units (HAU) of purified viral particles of MVMi and MVMt were subjected to the 
agarose-blot method. Filters were developed with the anti-VPs antibody and a chemiluminiscence 
method. 
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3.3.2. Quantitative analysis of capsid stability by the agarose-blot method. 
In order to test the reliability of this method in quantitative response, graded amounts of native 
purified DNA-filled viral particles (determined by an hemagglutination assay) of the MVMi and 
MVMt were loaded in 1.2% agarose, blotted, and developed under denaturing conditions with the 
anti-Vps antibody. As observed in Figure 13.B, this method allows a quantitative detection of both 
types of viral particles. The heterogeneous migration in the samples of the MVMt is particularly 
evident.  The apparent differential detection of the viral particles intensity may reflect the 50% 
error in estimation of capsid amounts by hemagglutination.  
3.3.3. Heat response of viral capsids analyzed by the agarose-blot method. 
The differential behavior of the MVMi/MVMt observed by TEM and HA analyses could be 
accounted by several mechanisms: full capsid disassembly, partial loss of capsid 
integrity/configuration, or genome ejection. To study the possible mechanisms involved, we 
analyzed the thermostability of viral capsid configuration by the agarose-blot method. Highly 
purified MVMi and MVMt viruses were subjected to different temperatures (from 37°C to 85°C) 
loaded in agarose gels, and blotted to nitrocellulose membranes. Filters were developed with the 
α-Capsid and α-B7 the antibodies to detect the preservation of the entire capsid configuration or 
the major 3fold-capsid epitope, respectively. Signal intensity was quantified by ImageJ program. 
The results are outlined in Figure 14.  
Some major comments on the Results obtained by this method are: 
-Configuration of capsid epitopes in response to heat.: (i) The overall capsid epitopes of MVMi are 
more resistant to heat than those of MVMt, as more capsid proteins remained reactive in viral 
particles to the Capsid-antibody, mainly at 50 °C, but also at higher temperatures; (ii) there is a 
progressive loss of capsid epitopes in both virus suggesting particles disassembly, withan 
approximate KD50 of 52 °C for MVMt and 62 °C for MVMi; (iii) Consistently, the 3x major epitope 
recognized by the B7-Mab is much more resistant to heat in MVMi than for the MVMt across the 
50-70 °C interval, as judged by the B7-MAb staining of the viral particles. These results strongly 
suggest that the thermostability of DNA-filled viral capsids is mainly regulated by the configuration 
of the B7-epitope on the 3x-axis of the capsid, and that this epitope is much more resistant in 
MVMi than in the MVMt. 
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Figure 14. Agarose-blot analysis of the heat response of viral capsids.  
The figure shows an agarose-blot analysis upon treatment of purified MVMi (blue) and MVMt 
(red) viral particles to the indicated temperatures for 10 min in PBS. The concentration of viral 
capsids was normalized by hemagglutination. Filters were proceeded for native staining with the 
anti-MVM capsid (upper image) or anti-B7 (lower image) antibodies, and the quantitative results 
are shown to arbitrary units of densitometry in the right. Representative results from two 
experimental determinations are shown.  
 
- Heat effect on viral particles mobility in gels: (i) There is an irreversible change of mobility in both 
viruses (manifested as a faster mobility band) happening at 50 °C and maintained at higher 
temperatures, although this shift may not be completed for the MVMt until 60 °C; (ii) Viral 
particles in both configurations are equally recognized by the B7-Mab, indicating that the 
configuration of this 3x-epitope is not related to the mobility shift.  
3.4. Virus genome uncoating and infectivity in response to heat  
The degree of capsid disassembly of DNA-filled viral particles in response to heat was 
quantitatively determined by measuring the uncoated ssDNA virus genome susceptible to DNAse. 
For this, normalized amounts of hemagglutination units of highly purified wt and mutant viral 
particles were treated 10 minutes under the corresponding temperatures shown in Figure 15. 
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Samples were next digested with DNase (Promega) for 2 hours at 37°C to remove the exposed 
DNA, and the remaining protected DNA in the samples was extracted by Qiagen DNeasy Blood and 
Tissue kit (refer to M&M: 4.1.1). Finally, the viral DNA was amplified by Real Time PCR with specific 
MVM primers (refer to M&M: 4.2.1). The assay was performed at least three times for each 
condition to obtain reliable determinations of the amount of exposed viral genomes in each 
sample with standard deviations. 
As shown in Figure 15A, the genome of viral particles maintained at 4 °C are fully resistant to 
DNase due to natural capsid protection. As viruses were subjected to temperature raise, the 
genome became progressively exposed to DNase due to loss of capsid protection or uncoating. 
The curves of uncoating for MVMi and the MVMt showed dissimilar kinetics with major 
differences between viruses at the 55-70 °C interval. The MVMi kinetics followed a sigmoidal curve 
suggesting a cooperative process across 50-60 °C, whereas the MVMt kinetics did not adjust to 
sigmoidal curve, showing increased genome resistance to DNase at this temperature interval, as 
its genome could be amplified to higher levels than that of MVMi. This result indicated that during 
viral conformational changes, which lead to uncoating induced by heat in vitro, the ssDNA genome 
is better protected by the MVMt capsid than the MVMi capsid. Therefore, the T/A mutation 
lowers or restricts the changes in capsid configuration induced by heat that leads to genome 
uncoating. 
To analyze the effects that the physical treatments had on infectivity, which is the major biological 
virus property, highly purified wt and MVMt DNA-filled viruses were subjected to heat under the 
conditions described above, and the infectious titer determined by a plaque assay on NB324K cells 
(see M&M: 2.3.4.1). As shown in Figure 15B, the MVMt maintained infectivity to higher levels than 
the MVMi across the heat treatment. Interestingly, the MVMi infectivity decayed mainly at the 55-
65 °C interval, whereas the MVMt infectivity decay was more progressive and occurred along the 
entire range of temperatures. Thus, the different response to heat of the virus infectivity fairly 
reflects the genome uncoating curves showed in Figure 15A. 
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Figure 15. Analysis of MVMi and MVMt genome uncoating and infectivity in response to heat.  
A: qPCR quantitative analysis of the DNase-resistant viral genomes upon subjecting purified MVMi 
and MVMt viral particles to the indicated temperatures for 10 min in PBS. The concentration of 
viral capsids was normalized by hemagglutination. Average values with standard errors from 
experiments performed in triplicated with different viral stocks are shown. B: Heat effect on MVMi 
and MVMt infectivity. Viral samples were treated as in A and subjected to a plaque assay on 
NB324K cells. The results are the mean with standard errors from two independent experiments 
performed in triplicate.  
 
3.5. Heat effect on VP2/3 cleavage and virus mobility in agarose electrophoresis.  
The mature MVM virion exposes about 20 amino acids of the n-terminal sequence (Nt) of the VP2 
major structural protein (2Nt) out of the coat, thereby allowing its cleavage by trypsin and other 
proteases in vitro (Sánchez-Martínez et al., 2012 and references therein). We tested whether the 
2Nt exposure in response to heat may differentially influence the behavior of the MVMi and 
MVMT virions in native agarose gels. Highly purified virus particles were heated at serial 
temperatures for 10 min, then cooled on ice, and subsequently digested with excess of trypsin. 
Samples were loaded into native agarose gels to test virions configuration (Figure 16A), as well as 
in SDS-PAGE (Figure 16B) to determine VP1, VP2 and VP3 proteins integrity and resistance to 
trypsin cleavage.  
 
 
 48 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Effect of VP2/VP3 cleavage on MVM mobility in agarose gels. 
A: Purified samples of the respective viruses heated at the indicated temperatures were 
subsequently digested with trypsin at 37 °C and analyzed by the agarose-blot method. Filters were 
developed under denaturing conditions with the anti-VPs antibody. B: Parallel analysis performed 
with the same samples by conventional SDS-PAGE and western-blot. The results are illustration of 
two independent experiments.  
 
As shown in Figure 16, both viruses maintain their capsid configurations resolved by agarose up to 
70 °C, whereas at 75 °C a complete capsid disassembly allows trypsin digestion of VPs subunits. 
Also in both viruses, the VP1 became cleaved since 55 °C. In spite of these identities, this analysis 
allowed to identify some major differences between both viruses that can be summarized as 
follows: 
I) The VP2 protein can be quantitatively cleaved to VP3 in the MVMT virus subjected at any 
temperature treatment. However, the VP2/3 cleavage in the MVMi virion is more sensitive to 
heat, indicating a differential exposure of 2Nt in response to heat between both viruses.  
II) The trypsin digestion switches the electrophoretic mobility of both viruses in native agarose 
gels. In particular, trypsin digestion without previous heating (samples remaining at 37 °C) leads to 
the loss of heterogeneous mobility of virus samples, an effect particularly drastic in the MVMT 
mutant. This result indicates that the 2Nt exposure is at least partially responsible for the 
characteristic heterogeneous mobility of the viruses in agarose gels, with more pronounced effect 
for the MVMT mutant.  
III) The MVMT virion is poorly resolved in agarose gels in the range of 50-70 °C, but became 
focused upon trypsin digestion. This observation suggests that the heated MVMt virion behaves as 
a particle of heterogeneous configuration, with differentially exposed 1Nt and 2Nt sequences that 
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affect its navigation through the agarose gel net. This heterogeneity in gel is lost when trypsin 
cleaves these N-terminal sequences of the VPs subunits.  
 
4. Effect of pH combined with temperature on MVM genome uncoating and infectivity. 
Parvovirus entry involves trafficking through the low pH and other stress conditions of the 
endosomal network. This process is necessary for the viral particles to undergo the structural 
changes leading to successful infection, but paradoxically it may also inactivate the incoming virus, 
thereby representing a major barrier against cell invasion. We therefore analyzed the viral 
particles integrity and infectivity under conditions that may mimic the endosomal environment. 
For this, highly purified MVMi and MVMt viral particles were subjected to a range of temperatures 
under neutral (7.5) or a mean endosomal pH value (5.5), and their integrity was assessed by 
genome uncoating.  
The efficiency of uncoating was indirectly studied by DNase digestion of unprotected genomes, 
and determination of undigested ssDNA was assessed by qPCR with specific MVM primers. Heat 
may alter the structure of viral capsids so the uncoated DNA can be digested by the DNase. The 
conditions of the reaction performed to study the thermostability of these viruses (time, pH, DNA 
extraction method, doses of enzyme, and qPCR) are indicated in the 2.3.2 section of M&M. The 
Figure 17.A illustrates the results obtained under these conditions. At pH 7.2 the genome 
uncoating drastically differed between both viruses across the range of temperatures tested. 
MVMi holds packaged genome efficiently up to 45 °C, but most viral particles drastically uncoat by 
55 °C. In contrast, the MVMt genomes remained significantly intact to 60 °C, but lost capsid 
protection at higher temperatures. When the study was performed at pH 5.5 however, while the 
kinetic of genome uncoating for the MVMt was similar to that of neutral pH, the MVMi genomes 
remained essentially full protected by the capsid even at 60 °C. Therefore, a low pH environment, 
as registered across the endosomal traffic network, remarkably prevents the MVMi genome 
uncoating in vitro, but it does not affect this process in the MVMt. 
 To seek for a biological relevance of this observation, the same virus samples subjected to 
pH and temperature treatments were analyzed for infectivity. Figure 17.B shows the plaque 
forming capacity of the treated viruses. The data shows that the MVMt plaque forming capacity 
was irrespective of the pH used for the heat treatments. However, the MVMi plaque formation 
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was highly benefited from a low pH buffering while heating. These results are in perfect 
correlation with the genome uncoating test performed with these samples outlined in Figure 17.A, 
indicating that the gained relative infectivity of MVMi at low pH is most likely due to the increased 
genome protection by the capsid coat.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Effect of pH on temperature-induced genome uncoating and infectivity.  
A: Purified viral samples were subjected for 10 min at the two pHs and indicated range of 
temperatures, and subsequently digested with DNase. The remaining DNA was extracted by 
Qiagen DNeasy Blood & Tissue Kit and analyzed by a qPCR assay. Values are the mean with 
standard errors from three independent determinations. The thermostability of the MVMi virus in 
acidic pH is remarkable when compared to that of MVMt.  B: Effect of temperature under 
different pHs on MVM infectivity. Purified viral samples subjected to the mentioned pHs and 
temperatures treatments were inoculated on NB324K cell monolayers, and PFU formation scored 
at 6 dpi. The ratio of plaque forming capacity (obtained at pH 5.5 versus 7.2 and at the indicated 
temperatures) is represented. These data are the means with standard errors obtained for three 
samples per virus from two independent experiments. 
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5. Phosphorylation pattern of the MVMi and MVMt capsids 
Previous reports showed that the VPs protein subunits assembled in MVMp particles are modified 
by phosphorylation at serine and threonine residues (Maroto et al., 2000), and that these 
modifications differ between the empty and DNA-filled viral particles (Gil-Ranedo et al., 2018; 
Maroto et al., 2004). However, nothing is known about the modification of the MVMi capsid 
subunits. The different electrophoretic behavior of the MVMi and MVMt purified viral particles 
described above (see Figure 14), in spite of their identical VPs amino acid sequences, prompted us 
to investigate their post-translational modification. Firstly, we determined the extent of VPs 
phosphorylation in vivo. NB324K infected at high MOI by MVMi and MVMt were labeled with 32P-
orthophosphate at the conditions outlined in M&M: 2.4. The structural proteins were 
immunoprecipitated with anti-VPs antibody and resolved by SDS-PAGE. As shown in Figure 18.A, 
the level of MVMt VPs phosphorylation is significantly higher than that of the MVMi. This different 
degree of VPs phosphorylation was also observed in viral particles immnunoprecipitated with the 
Mab-B7 anti-capsid monoclonal antibody (data not shown). Therefore, newly synthesized and 
particle assembled VPs subunits of the MVMi and MVMt viruses are post-translationally modified 
to different extent by phosphates. 
In a second type of analysis on the possible contribution of subunits modification by phosphates in 
viral particles configuration, we studied their electrophoretic behavior. Purified empty capsids and 
DNA-filled viral particles of MVMi and MVMt were digested with phosphatase and subjected to 
native agarose gel-electrophoresis. We used Lambda phosphatase as the capacity of this enzyme 
to remove surface charges of the MVMp viral particles was recently described (Wolfisberg et al., 
2016). For this, similar amounts of highly purified empty capsids (C) and DNA-filled viral particles 
(V) were incubated with different doses of Lambda Phosphatase (NE Biolabs) at the conditions 
indicated above (see M&M: 2.5). Digested viral samples were adjusted to 5% glycerol, subjected to 
1.2% Agarose gel electrophoresis at 4 °C for 2 hours at 80V, and blotted to nitrocellulose 
membranes.  Figure 18.B shows a representative result of this kind of experiment developed with 
the α-VPs antibody under denaturing conditions (refer to M&M: 4.5.3.). The increasing dose of 
phosphatase clearly alters the gel mobility of empty and DNA-filled viral particles, in both MVMi 
and MVMt. The change in the pattern of mobility observed is similar in both viruses, but 
PROTECTED DATA 
PROTECTED DATA 
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characteristic for each type of particle: empty capsids increased mobility as the phosphatase doses 
increased. Whereas, the mobility of DNA-filled viruses decreased it at similar extent. The reason 
why the different type of particles response specifically to lambda phosphatase in unclear. In 
addition, the bands of full MVMt virus tend to sharp in focus upon phosphatase action, suggesting 
that the heterogeneous mobility of these particles in gel is due to (at least in part) phosphate post-
translational modifications. These experiments led us to conclude that the VPs subunits assembled 
in the MVMi and MVMt are modified by phosphates to a different extent, and that modification 
alters the electrophoretic mobility of viral particles in agarose gels.   
 
 
 
 
 
 
 
 
 
 
Figure 18. Phosphorylation of MVMi/t capsid subunits.  
A: The Capsid subunits of MVMt harbor a phosphorylation level higher than that of the MVMi in 
cells. The figure shows the level of phosphorylation of MVM capsid subunits immunoprecipitated 
with anti-VPs antibody under denaturing conditions from in vivo 32P-labeled 10e6 infected NB324K 
cells. Left: immunoprecipitated VPs developed with a mouse anti-VPs antibody with a 
chemoluminiscence method. Right:  in vivo 32P-labeled immunoprecipitated VPs resolved by SDS-
PAGE and blotting. Filters were exposed to autoradiography. Two independent determinations are 
shown. B: Lambda Phosphatase alters purified MVMi and MVMt particles mobility in agarose gels. 
The same hemagglutination units of purified MVMi and MVMt capsid (C) and virus (V) particles, 
digested with the indicated doses of Lambda phosphatase, were resolved by agarose gel 
electrophoresis and western blot. The experiment was repeated twice with similar outcome. 
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6. Role of the endosome in the MVMi and MVMt entry pathway.  
The entry process of Parvovirus, particularly in MVM, is very sensitive to the endosomal pH. 
Indeed, it was described that MVMp requires low pH of the endosome for efficient infection (Ros 
et al., 2002), and moreover the bulk of the incoming MVMp particles does not escape from the 
endosome (Garcin and Panté, 2015) (see 4.3. of introduction). However, no data is available for 
the entry process in the MVMi infection. We therefore tested whether endosomal traffic may 
underlie the MVMi/MVMt differential specific infectivity.  
6.1. Effect of endosomal inhibitors on MVMi and MVMt gene expression. 
For this experimental approach we tested successful infections by monitoring the expression of 
the NS1 protein, the large main cytotoxic product of MVM. NB324K cells were inoculated with 
purified MVMi and MVMt. The latter virus was used at two multiplicities in order to normalize the 
infection for the total amounts of viral particles (UHA) or infectious particles (PFU), in respect to 
the single dose of MVMi that was used. After adsorption, endosomal inhibitors were added to the 
medium and infection was allowed to proceed for 20 hours. Cells were subsequently inspected for 
NS1 expression by IF, and collected data were quantitatively recorded in several fields of cells from 
duplicate experiments. As observed in Figure 19, the percentage of cells expressing NS1 in the 
presence of 2.5 µM ClQ declined to 50% in case of MVMt, whereas MVMi required a higher ClQ 
concentration close to 5 µM for a similar inhibition. Likewise, in the presence of 10mM NH4Cl, the 
amount of MVMt infected cells expressing NS1 reached 50%, while MVMi required 25 mM. Thus, 
the MVMt was significantly more inhibited than MVMi by Chloroquine as well as by NH4Cl. 
Therefore, both endosomal inhibitors indicated that the MVMt is much more sensitive to the low 
pH during endosomal sorting for entry than the MVMi virus. These data suggest that capsid post-
translational modifications may determine a structural plasticity that is advantageous for 
endosomal trafficking and successful infection. 
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Figure 19. Effect of endosomal inhibitors on viral NS1 protein expression.  
Cells seeded onto coverslips were inoculated with normalized amounts of infectious units 
(PFU/cell) of the MVMi or MVMt, and the NH4Cl and Chloroquine inhibitors were added at the 
indicated concentration post virus adsorption. A: Representative fields of cells stained for NS1 
expression at 24 hpi. At least one thousand cells were counted per virus and condition. B: Cells 
undergoing NS1 expression in the presence of endosomal inhibitors. Right: Inhibition with NH4Cl. 
Left: Inhibition with Chloroquine doses. Data (average and standard errors) from two independent 
experiments are shown  
6.2. Intracellular features of entering MVMi and MVMt virions. 
6.2.1. Capsid subunits and viral genome association of the incoming viral particles. 
We sought intracellular features in virions and capsids at early times post infection. NB324K cells 
were infected with normalized amounts of viruses, and viral samples were harvested at different 
time points to be resolved under native conditions by the agarose-blot method. Filters were 
probed (in parallel blots) for VPs and ssDNA viral genome. This study aimed to identify changes in 
viral capsid integrity/mobility inside the cells and their association to the viral genome. Heat-
denatured viral control samples showed released genome (Figure 20, 90°C lower filter), and the 
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migration of the disassembled capsid proteins as a faint band at the front of the gel (Figure 20, 
90°C upper filter). As expected, the MVMi and MVMt heat-uncoated ssDNA genomes migrate at 
the same position in the gel. However, in native virion samples, the genome migrates at the same 
position of the corresponding VPs, indicating capsid packaging. As outlined above, the 
modifications of capsid subunits alter the characteristic mobility of intact viral particles (MVMt 
virions moving slower than MVMi), and therefore of the packaged genomes. 
Viral samples were harvested along hours post-infection (HPI) to be analyzed by this method. As 
observed in Figure 20, the pattern of capsid proteins-viral genome association from each virus 
remained at the characteristic mobility in all samples. The resolved viral genomes migrated at the 
position of capsids during early stages of virus entry. This ssDNA-VPs association suggests that a 
significant fraction of the genome is maintained packaged within capsids along the entry process., 
although the extent of this process may vary between viruses (unclear study). At late times of the 
infection (16 hpi) the synthesis of VPs and of viral DNA is patent in both viruses, denoting their 
high infectivity in this cell system. 
 
 
 
 
 
 
 
Figure 20. Viral genome association to VPs along early times of MVM infection.  
NB324K cell monolayers were inoculated with normalized amounts of purified viruses (180 
UHA/10e5 cells). The samples of homogenized cells, collected in PBS at different hours post-
infection (hpi), were resolved by native agarose-blot gels. Each sample was simultaneously loaded 
on two equivalent agarose gels running in parallel at 4 °C. Upper, blots of viral samples probed 
with anti-VPs antibody under denaturing conditions (see MM). Lower, agarose gels blotted to 
nylon membrane by alkali method, showing the ssDNA genomes resolved by hybridization with a 
32P-labeled MVM probe (see MM). The co-migration of the VPs and ssDNA in the gels is illustrated 
by the rulers (left margins). Virus particles in their native configuration at 4 °C (V) and heat 
disassembled (90 °C) were loaded as control. 
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6.2.2. Viral particles configuration along the entry pathway.  
The co-migration of VPs with genome ssDNA in gels suggested packaging, but did not inform about 
the configuration of the viral capsid. This issue was addressed by studying changes in the capsid 
epitopes along early stages of virus cell entry. Purified virus or empty capsids applied on NB324K 
cells were sampled along the time and loaded in agarose gels under native conditions as above. 
But blots were probed with the anti-MVM capsid antibody that mainly recognizes capsid 
configuration epitopes. Figure 21.A shows that MVMi and MVMt empty capsids progressively lost 
antibody recognition from 2 to 8 h post-adsorption. The same pattern of loss of antibody 
recognition along the time was observed for the MVMt virus samples Figure 21.B, as well as in 
MVMi virus samples (data not shown). We therefore conclude that although the ssDNA genome 
remains likely packaged, the entering viral capsids undergo conformational changes along the 
endosomal pathway involving the loss of capsid configuration epitopes.  
 
 
 
 
Figure 21. Configuration of capsid epitopes in trafficking virus.  
NB324K cell monolayers inoculated and sampled as above were loaded on agarose gels and run at 
4 °C. Gels were blotted to nitrocellulose filters under native conditions and probed with the anti-
MVM capsid antibody. A: Empty capsids sampled at the indicated hours post-adsorption. B: 
Purified viral particles of MVMt analyzed post-adsorption time. Filters were developed (ECL, 
Amersham) and exposed to autoradiography for 5 min. 
 
6.2.3. Confocal analysis of intracellular virus traffic.  
Putative differences between the intracellular traffic of both viruses were finally studied by 
confocal microscopy. For this, NB342K cells monolayers inoculated with normalized amounts of 
purified viral particles were fixed at serial time points, and capsid proteins and DNA of the 
incoming viral particles were stained by IF. Figure 22 shows a panel of representative fields of 
these experiments. MVMi and MVMt viral particles could be identified at 0 hpi post-adsorption by 
a faint DNA staining. As the infections proceeded, the staining with all markers (intact 
Capsid/capsid proteins/viral DNA) significantly increased (Figure 22, panels 2 and 6 hpi), denoting 
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a presumed accumulation of incoming viral particles in endosomal vesicles. The signals under 
confocal inspection were consistently higher for the MVMt versus the MVMi, which may suggest a 
higher intracellular stability of this virus. Capsid proteins and DNA of both viruses were detected 
by high accumulation at 22 hpi in most cell’s nuclei, reflecting a de novo synthesis of viral 
macromolecules by the high multiplicity of infectious virus used.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Intracellular traffic of the MVMi and MVMt viral particles.  
NB324K cells were inoculated with normalized amounts (16 UHA/10e5 cells) of MVMi (equivalent 
to MOI 5) and T-mutant (equivalent to MOI 500) viruses. The figure shows confocal analysis of the 
intracellular accumulation of incoming MVMi and MVMt viruses as stained with intact-capsid (B7-
Mab), capsid general epitopes (anti-MVM) and viral DNA (FISH). Representative fields of cells at 
the indicated hours post-infection (HPI) are shown. DAPI represents cellular nuclear DNA.  
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Interestingly though, neither staining of capsid proteins nor viral DNA was detected inside the 
nucleus at any early time points (0-6 hpi). Rather, MVMi and MVMt macromolecular signals 
accumulated at the nuclear periphery without significant nuclear invasion. Given the high specific 
infectivity of the MVMt virus (see above), these results may suggest a saturation of the cellular 
transport system by the amount of viral particles used in this set of experiments. Lower amounts 
of input virus however did not allow clear IF staining (data not shown).  
7. Comparative study of killing capacity of MVMi vs MVMt in human cancer cells. 
 The differential physicochemical properties and endosomal trafficking of MVMi/MVMT viruses 
were translated into a comparative study on the interaction of these viruses with human cancer 
cells. This study was aimed at assessing whether these properties increase their oncolytic capacity 
in culture. For this, we tested their killing capacity by colony forming assays performed in the 
NB324K reference cell line used to grow the virus. Figure 23A, left shows representative results of 
these experiments. Infecting with normalized amounts of purified viral particles, the killing of 
NB324K was more than fifty times efficient by MVMt than MVMi along the multiple tested doses. 
This is reflected by the ID50 estimated for of each virus: less than 1UHA/10e5cells for the MVMt, 
and almost 100UHA/10e5cells for the MVMi. In parallel to the infections performed on NB324K 
cell monolayers, the expression of the NS1 viral cytotoxic protein was determined by IF. Figure 23B 
shows that the number of NS1+ expressing cells was much higher for the MVMt than MVMi at all 
tested doses. We conclude that the MVMt harbors a much higher oncolytic capacity than MVMi, 
at least against this transformed human cell line. Interestingly, the percentage of killed cells (cells 
unable to develop colonies in the CFU assay) was significantly higher as compared to NS1+ cells, 
suggesting that delayed or low levels of NS1 expression may however prevent colony formation.  
The study was extended to the U87-MG cells, a human glioblastoma cell line that is permissive to 
MVMi cytotoxic infection (Rubio et al., 2001). As shown in Figure 23A, right panel, both viruses 
efficiently killed these cells, although survival was slightly lower in MVMt infection. This result 
indicated that virus trafficking during entry, or other intracellular factors determining 
MVMi/MVMt different specific infectivity, may drastically differ between human cancer cells. 
 
  
PROTECTED DATA 
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Figure 23. Analysis of the cytotoxic effect of MVMi and MVMt in human cancer cells.  
A: Effect of MVMi and MVMt on survival of human NB324K (left) and U87-MG glioblastoma (right) 
cancer cells as determined by colony forming capacity. B: Ratio of NB324K cells expressing NS1 
determined by IF. Values were obtained from a minimum of five hundred cells scored from at least 
four fields of cells from two independent infections.  
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Section B: Endogenization of some members of the Parvoviridae in primate 
genomes. 
 
1. In silico evidences of ESVEs in primate genomes.  
Endogenous parvovirus elements are widely distributed in vertebrate and invertebrate genomes 
(Arriagada and Gifford, 2014; Belyi et al., 2010; Kapoor et al., 2010; Katzourakis and Gifford, 2010; 
Liu et al., 2011), but their presence in primate genomes has not been studied in depth. We thus 
screened the primate genomes available in databases for endogenous single-stranded DNA virus 
elements (ESVEs). The initial search was performed with eight representative members (MVM, 
AAV2, BPV, PBoV4-1, B19, PARV-4, AMDV-G and GmDNV), but it was subsequently extended to all 
members of the Parvoviridae, with a similar outcome. As shown in Table 12, a remarkable number 
of ESVEs of variable lengths belonging to the Parvoviridae was found at high significance in the 
chromosomes of different primate species from the Cercopiticidae. Most primate ESVEs were 
significantly homologous to the Rep and Capsid genes of the Adeno Associated Virus (AAV) species 
belonging to the Dependoparvovirus genus of the Parvoviridae. Although no infectious entities of 
the Dependoparvovirus genus have been isolated so far in monkeys (Cotmore et al., 2014), we 
named these endogenous parvovirus sequences, based on their sequence identity, as Simian 
Dependoparvovirus Elements (SDEs). The respective primate host, nomenclature, and accession 
number of all the SDEs identified in this work are summarized in Table 13. 
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Table 12. Bioinformatic results in Primates 
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Table 13. Nomenclature of endogenous parvoviridae sequences in Cercopithecidae  
Acronym Formal Name Accession # 
SDECat42 
Simian Dependoparvovirus Element Cercocebus atys  
(scaffold42) 
NW_012004166.1 
(1691323 - 1693695) 
SDECat60 
Simian Dependoparvovirus Element Cercocebus atys 
(scaffold60) 
NW_012006154.1 
(2893791 - 2895431) 
SDECdi Simian Dependoparvovirus Element Cercopithecus diana Pending EMBL 
SDECsa Simian Dependoparvovirus Element Chlorocebus sabaeus 
NW_006735234.1 
(18697380 - 18698248) 
SDECan Simian Dependoparvovirus Element Colobus angolensis 
NW_012115044.1 
(2545922 - 2546615) 
SDEMle Simian Dependoparvovirus Element Mandrillus leucophaeus 
NW_012100998.1 
(1005600 - 1007239) 
SDEPan11 
Simian Dependoparvovirus Element Papio anubis 
(chromosome 11) 
NW_003876533.1 
(31932 - 33572) 
SDEPan3 
Simian Dependoparvovirus Element Papio anubis 
(chromosome 3) 
NW_003872382.1 
(331923 - 334302) 
SDEPha11 
Simian Dependoparvovirus Element Papio hamadryas 
(chromosome 11) 
… 
SDEPha3 
Simian Dependoparvovirus Element Papio hamadryas 
(chromosome 3) 
… 
SDETge Simian Dependoparvovirus Element Theropithecus gelada Pending EMBL 
 
 Although not identical to the known AAVs, the percentage of amino acid identity of SDEs with the 
Rep and Cap proteins of the currently circulating parvoviruses was in the range of 86 - 93% for 
Rep78 in Colobus angolensis and Chlorocebus sabaeus respectively, and 71% for VP2 and 76% for 
VP1 in Papio anubis and Cercocebus atys (Table 12), which is above the criteria of species 
assignments by the ICTV (Cotmore et al., 2014). In some cases, matches of homologies were 
remarkably exact (E-value 0.0). Hence, in extant primates with available assembled genomic data, 
the ESVEs showed drastic uneven distribution, with a high presence focused in the 
Cercopithecidae. However, other studied primate families such as new world monkeys (Cebidae: 
Aotus, Callithix, Saimiri, Sapajus), asiatic tarsier (Tarsius) and the great apes (Pongo, Pan, Gorilla, 
Homo) of the superfamily of the Hominicidae, including the Hylobatidae and Hominidae families, 
gave no matches for ESVEs.  
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1.1. Searching ESVEs in the Hominidae.  
The BLAST study of ESVEs in Hominidae, didn’t show any significant similarity. This 
finding was difficult to reconcile with the previous suggestion of an AAV-like insertion in 
the H. sapiens genome (Liu et al., 2011). We thus explored this important issue by 
molecular analyses, including southern-blot and PCR analysis performed in thirty genomic 
DNA human samples. Firstly, primers were designed from the consensus region of 
endogenized Rep gene in primates and the human samples were subjected to PCR 
amplification. Surprisingly, two out of the thirty samples amplified the expected size. These 
amplicons were extracted from the gels, undergone DNA sequencing and the existence of 
AAV like sequence was confirmed. On the other hand, Southern-blots using AAV probes 
failed to detect bands of related sequences (see examples in Figure 24.A). Further studies, 
such as deeper bioinformatics “in silico” search and molecular confirmation of the 
endogenous nature of AAVs obtained in these two samples are under investigation. 
 
 
 
 
 
Figure 24. Analysis of the presence of endogenous Parvovirus elements in human genomes.  
A. Southern-blot analysis of the presence of AAV sequences in humn genomes. Left: agarose gel 
electrophoresis of BamH-I restricted human DNA samples. M: molecular weight markers, 1-3: 
human samples, +: AAV positive control (a BamH1 digestion of the pH22 plasmid). Right: southern 
blot analysis of the same samples hybridized with a AAV 32P-labeled probe. B. PCR analysis of the 
presence of AAV sequences in human samples. Primers were designed to amplify a Rep conserved 
region, the expected amplicon length being 434bp. Only 2 out of 30 human samples yielded the 
expected fragment. 
1.2. Distribution and genetic structure of SDEs in the Cercopithecidae. 
In Catarrhini monkeys, a collection of SDEs was found in different members of the Cercopithecidae 
family, which basic genetic structures are represented in Figure 25. The Cercopithecidae SDEs were 
all of highly significant nucleotide homology to the parvovirus AAV2 (Fig. 26). The coding regions 
within the Cercopithecidae SDEs consisted mainly in fragments of the Rep gene under four 
configurations (see Fig. 25): (a) a short Rep (1-143 amino acids), unique to Colobus angolensis; (b) 
a 1-242 aa fragment, present in Chlorocebus sabaeus and Cercopithecus diana; (c) a larger 1-445 
aa fragment, shared by Mandrillus leucophaeus, Cercocebus atys and Papio anubis and (d) an 
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almost entire Rep gene (7-615 aa) plus an N-terminal fragment of about 180 aa of the capsid gene, 
shared by Cercocebus atys, Papio anubis, and Theropithecus gelada. Thereby the Papio anubis and 
Cercocebus atys primates harbored two independent insertions of SDEs in different chromosomes 
of their genomes. 
Figure 25. SDEs structures in the Cercopithecidae. 
Upper: genetic organization of the AAV2 genome. The coding regions of Rep proteins and the 
initiation sites of the capsid proteins (VP1, VP2, VP3) are highlighted. Cis-regulatory domains, as P5 
promoter and RBS (Rep binding site) within the ITR region are also illustrated. Below: size and 
genetic compositions in respect to the AAV2 genome) of the SDEs identified in the primate 
members of the Cercopithecidae. 
 The Cercopithecidae SDEs showed nucleotide homology above 80% to the currently circulating 
AAV2 genome (Table 12). This high conservation of nucleotide expanded uniformly across their 
sequences (Fig. 26) without modular heterogeneity, though the conservation was slightly higher in 
the REP coding regions than in the capsid gene fragment.  
Of note, the SDEs showed a high degree of cis-regulatory sequence conservation. This is illustrated 
in Fig. 25 and 26. The three almost identical endogenous sequences (SDECat60, SDEMle, and SDEPan11) 
remarkably maintained the B-C´-C-A-D regions, the Rep binding site (RBS), and the transcriptional 
regulatory sequence (TRS) of the AAV2 inverted terminal repeat (ITR) in the flip secondary 
structure. They do also conserve the P5 and P19 major viral promoters. A shorter A-RBS-TRS-D ITR 
also in the AAV2 flip configuration was found in the SDECan, which expanded up to include the P5 
promoter.  
 65 
 
 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Nucleotide alignment of some AAV genomes with the SDEs of Cercopithecidae. 
The figure shows the degree of nucleotide homology between AAV dependoparvoviruses with 
SDEs found in the Cercopithecidae primates. Some regions of the AAV2 genome, including 
regulatory domain, are represented. Color code is based in percentage of identity, and alignment 
is interrupted at the SDEs limits. Note: The general SDEs nucleotide homology are much higher 
compared to AAV2/7 than AAV5 sequences. 
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The rest of the Cercopithecidae SDEs lacked AAV-ITR sequences, although their composition 
included either the P5 (and its associated RBS) and P19 promoters (SDECsa, and SDECdi), or both P19 
and P40 promoters (SDEPan3, SDECat42, and SDETge). According to figure 26, high sequence similarity 
was observed in most SDEs at splice donor 527 (Stutika et al., 2016), and also in case of SDEPan3 and 
SDECat42 at splice donor 1906 (Trempe and Carter, 1988). In summary, the Rep gene and the AAV2 
cis-regulatory sequences showed high degree of conservation in the SDEs found in the 
Cercopithecidae. 
2. Molecular confirmation of the SDEs. 
To support and confirm (wherever possible) the in silico identified SDEs in the Cercopithecidae 
genomes and exclude possible pitfalls due to DNA contaminations (Naccache et al., 2013; Smuts et 
al., 2014), also to study some species for which no assembled sequences are available in databases 
yet, a large set of DNA samples obtained from primate organs were subjected to molecular 
analyses (Table 9). Primers were designed to amplify the different inserted SDEs, and in some 
cases the flanking sequences of the corresponding primate genome (Table 14). As shown in Fig. 
27, the presence of SDEs corresponding to a fragment of REP sequences of the expected size was 
demonstrated by PCR in the genome of some Cercopithecidae members, as for example: Papio 
hamadryas, Mandrillus sphinx, Cercocebus chrysogaster, Cercopithecus mitis and Theropithecus 
gelada. In all cases, the amplified bands were purified from the gels and their SDE origin was 
confirmed by Sanger nucleotide sequencing (not shown). Some SDEs, as SDECmi, SDETge and SDECdi,  
were found in species that had no genomic DNA available in major international nucleotide 
sequence databases (DNA DataBank of Japan (DDBJ), the European Nucleotide Archive (ENA), and 
the GenBank at NCBI). These novel SDEs were therefore submitted to ENA and Genbank databases 
with their unique accession numbers for further studies (Table 15). Consistently, DNA samples 
from primates lacking SDEs as predicted by in silico analysis, such as Macaca mulatta or Cebus 
capucinus, gave faint bands of non-corresponding sizes by PCR and upon gel-isolation their 
nucleotide sequences did not show homology to AAV (data not shown). Therefore, a general 
correspondence between the in silico and PCR analysis was obtained across this primate family. 
Interestingly, although the bioinformatic analysis predicted an SDE in Colobus angolensis (Fig. 25), 
PCR amplifications using different pairs of primers specifically designed for this SDE, as well as for 
flanking primate sequences, failed to detect this SDE in a sample from Colobus polykomos, 
suggesting different genome colonization by AAV between these two primate species.  
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Table 14. Primers used to amplifiy SDEs 
Oligo 
Name 
Seq 5'- 3' 
Tm 
SL 
bp 
Expected 
Amp. 
length 
Origin Purpose 
Papio-chr3-
1-forward 
5'-AATAGCGTAATGGGCAGGAAG-3' 54.4 21 
582bp Papio 
Amplify  3' flanking region 
in Papio chr3, Cercocebus 
Scaffold42 
Papio-chr3-
2-reverse 
5'-CAGGACGTGTAGGTGGAAATAG-3' 54.4 22 
Papio-chr3-
3-forward 
5'-GTTGAGGAAGTGGCTAAGACG-3' 54.7 21 
640bp Papio 
Amplify  5' flanking region 
in Papio chr3, Cercocebus 
Scaffold42 
Papio-chr3-
4-reverse 
5'-CCAGACACCGGAAAGAGGC-3' 56.5 19 
Rep-sense-
AAV 
5'-GTGAGTAAGGCCCCGGAGG-3' 58 19 
484bp AAV2 
Amplify Rep consensus 
sequence in primates 
Rep-
antisense-
AAV 
5'-GCCACCCGACCAGCTCCAT-3' 61 19 
Chr11-
Sense-
papio 
5'-TTGCGACATTTTGCGACACCA-3' 58.1 21 
556bp 
Papio Amplify ITR and Rep in 
Papiochr11, Cercocebus 
scaffold 60, Mandrill Rep-Nest-
AAV2-R 
5'-AGCACTCATCCACCACCTTGTT-3' 58.7 22 AAV2 
5’-Flank-
Mand-F 
5'-AGAAAATAGAAGCAAGACAGCAC-3' 53.6 23   Mandrill 
Amplify  5' flanking region 
in Papio chr11, Cercocebus 
Scaffold60 and Mandrill 
3'end 
Mand-F 
5'-CAGCAGCCCGTGGAGGAC-3' 58.8 18 
643bp Mandrill 
Detect the 3’ end of 
Cercopithecus 3'end 
Mand-R 
5'- GTTGTGTTTCATACCTTTTTGGCATC -
3' 
56.4 26 
3'end 
chloro-F 
5'-CTACCTGCTCCCCAAAACCCA-3' 58.6 21 
325bp Chlorocebus 
Detect the 3’ end of 
Cercopithecus 3'end 
chloro-R 
5'-TTGATGGACATTTGGGTTGGTTC -3' 56.1 23 
5-Chloro-F 5'-GTTTATTTTGTATTATGCAACCTTCC-3' 52.2 26 
489bp 
Chlorocebus 
Amplify  5' flanking region 
of in Cercopithecus 5-Chloro-
Cdi-R 
5'-CTATCAGATTCAGGTCCATGTCAG-3' 54 24 Cercopithecus 
5’-Colobo-
Flank-F 
5'-TTGCTATCACCAGACCTACCTTAC-3' 56.1 24 
775bp 
Colobus 
angolensis 
Amplify the whole insert in 
Colobus 3’-colobo-
Flank-R 
5'-CACTGATGAGCATTTAGGTTGATTCT-
3' 
56.2 26 
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Table 15. List of accession numbers obtained for SDE sequences 
Organism 
Given 
Name 
Accession 
code 
Description  Provider 
Release 
date 
Database 
Theropithecus 
gelada 
SDEtge-rep KU645401 
Endogenous 
AAV Rep 
EUPRIM-
Net Project 
16.11.2017 Genbank 
Theropithecus 
gelada 
SDEtge-3' KU645402 
3’ insertion 
site of 
endogenous 
AAV 
EUPRIM-
Net Project 
16.11.2017 Genbank 
Theropithecus 
gelada 
SDEtge-5' ERZ481217 
5’ insertion 
site of 
endogenous 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
Cercopithecus 
aethiops 
(Vero Cell line) 
SDEcaev-
rep 
ERZ496759 
Endogenous 
AAV Rep 
A. 
Carrascosa 
(ATCC) 
To be 
published 
ENA 
Cercopithecus 
aethiops 
(COS1 cell line) 
SDEcaec-
rep 
ERZ496758 
Endogenous 
AAV Rep 
A. 
Carrascosa 
(ATCC) 
To be 
published 
ENA 
Cercopithecus 
aethiops 
(COS1 cell line) 
SDEcaec-5' ERZ496757 
5’ insertion 
site of 
endogenous 
AAV Rep 
A. 
Carrascosa 
(ATCC) 
To be 
published 
ENA 
Cercopithecus 
mitis 
monoides 
SDEcmi-
rep 
ERZ481210 
Endogenous 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
Cercopithecus 
mitis 
monoides 
SDEcmi-
11r 
ERZ481209 
5’ region of 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
Cercopithecus 
diana 
SDEcdi-11r ERZ481208 
5’ region of 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
Cercopithecus 
diana 
SDEcdi-5' ERZ481207 
5’ insertion 
site of 
endogenous 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
Cercopithecus 
diana 
SDEcdi-3' ERZ481206 
3’ insertion 
site of 
endogenous 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
Papio 
hamadryas 
SDEpha11-
3' 
ERZ481216 
3’ insertion 
site of 
endogenous 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
Papio 
hamadryas 
SDEpha11-
11r 
ERZ481215 
5’ region of 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
Mandrillus 
Sphinx 
SDEmsp-
rep 
ERZ481214 
Endogenous 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
Cercocebus 
chrysogaster 
SDEcch-rep ERZ481205 
Endogenous 
AAV Rep 
EUPRIM-
Net Project 
To be 
published 
ENA 
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Figure 27. Molecular analysis of the SDEs found in primate genomes.  
DNA samples obtained from the indicated primates were analyzed by PCR. Primers Rep-sense-AAV 
and Rep-antisense-AAV (amplifying 484bp of rep gene located between nucleotide positions 527 
to 1011 of AAV genome, see Table 15) were used. The PCR products resolved by an 1.5 % agarose 
gel are shown. Negative control: DNA sample from human. MW, molecular weight markers 
(Thermofisher Scientific). 
 
2.1. Exploration of SDEs in Primates with unavailable genomic data. 
To extent our molecular analysis to primates of which genome sequences are not available in 
databases yet, we obtained DNA from the liver of Theropoithecus gelada, Cercopithecus mitis, 
Lemur catta to examine the presence of SDEs in their genomes. Southern-blotting was performed 
on BamHI, HindIII and EcoRI digestion products, hybridizing at high stringency with a probe 
containing the Rep and VP genes of AAV2 (see Materials and Methods: 4.3). The pattern and sizes 
of positive bands (Fig. 28, lower), when compared to restriction patterns expected for the 
phylogenetically closer reference primates genomes (Fig. 28, upper), were consistent with single 
insertion of a SDE of high homology to AAV2 in Theropithecus gelada (pattern identical to that of 
chromosome 3 of P. anubis), and other unique insertion of apparent lower homology in 
Cercopithecus mitis (pattern similar to Chlorocebus sabaeus, except for a HindIII fragment). These 
results illustrated the likeliness of findings, based on genomic sequencing, additional SDEs as it 
became extended to other primates. 
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Figure 28. Southern blot analysis of SDES in primate genomes.  
Upper: scheme of expected location of restriction sites in AAV2 and the reference primate 
genomes. Lower: Results obtained by the indicated primate genomes. A total of 10 μg of genomic 
DNA was digested with enzymes (B= BamHI; E= EcoRI and H=HindIII) and loaded per lane. Filters 
were hybridized with AAV probe and exposed for two weeks to intensifying screens at -70 °C. 
Marker track was HindIII-digested λ phage DNA that was loaded in parallel.  
2.2. Study of SDEs flanking sequences in Cercopithecidae 
Prompted by mentioned findings, we focused on molecular analysis of the SDEs insertion sites that 
could rule out the undesired components in the samples (like not-integrated episomal DNA, AAV 
viral particles of ongoing infections, or putative contaminations mentioned above) which could 
mislead our study on genuine endogenous parvovirus elements inserted in primate germ lines. For 
this, the 5´and 3´flanking regions of a large collection of the putative SDEs were amplified by PCR 
using specifically designed flanking primers amplifying the SDEs-primate genomes contact 
sequences (Table S4). As shown in Fig. 29, the resulting amplified PCR fragments fulfilled the 
expected sizes of the 5´and 3´flanking sequences, and furthermore were isolated from the gels 
and sequenced to demonstrate their endogenous nature (table new accession No). Only the 
SDEPan11 and SDEMle 5´-flanking amplified sequences yielded an additional band of lower 
molecular weight of not reliable repeated sequence, in consistency with the presence of predicted 
 71 
 
 Results 
entire 5´-ITR within (Fig. 25), which commonly altered secondary structures and made the 
sequencing of parvovirus PCR amplification fragments difficault (unpublished observations). 
Moreover, this analysis allowed us to differentiate between the double SDEs insertions in the 
genome of Papio anubis. In summary, the consistency of in silico and molecular analyses of SDEs in 
the Cercopithecidae led us to conclude that their SDEs are genuine parvovirus endogenous 
elements that colonized the germ line of many species in this family of primates.  
 
 
 
 
 
 
 
 
Figure 29. Analysis of the integration sites of SDEs in primate genomes.  
PCR amplification products obtained in several members of the Cercopithecidae by primers 
designed for the 5´and 3´ SDE/primate genome junctions (see Table 15). Molecualr weight markers 
(Thermofisher) are shown to the left.  
 
3. Conservation of parvovirus protein motifs in SDEs. 
Parvovirus genome encodes several multifunctional non-structural proteins (mentioned as Rep or 
NS), and two-three structural capsid proteins (VPs). We analyzed the conservation of the best 
characterized parvovirus protein domains, motifs and residues across the identified SDEs 
sequences. Figure 30 illustrates this type of analysis focused on the rep gene, in which several 
SDEs of Cercopithecidae are compared with the circulating related AAV2, AAV7, AAV8 and the less 
related AAV5 parvoviruses. Two domains of Rep proteins were carefully analyzed, the Ori domain 
involved in parvovirus DNA binding (Ashktorab and Srivastava, 1989; Maggin et al., 2012)  which 
consists of the 100-160 amino acid residues of the protein, and the Helicase domain, also essential 
during virus genome replication (Walker et al., 1997), encompassing the 380-450 amino acid 
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residues stretch. As shown in the figure, high conservation of residues between endogenous and 
exogenous parvovirus sequences was observed in both REP domains, remarkably in the residues 
essential for catalytic activities of domains, as the motifs III in the Ori domain (including two 
important histidine residues), and the Walker B, B´, and C of the helicase (including important 
residues as the two glutamic acids of walker B and the arginine in the last position of the 
alignment) and transactivation domain (arrows in Figure 30). This analysis demonstrated that Rep 
catalytic activity of viruses resulting in SDEs was proceeded through the residues analogous to the 
ones used by currently circulating AAVs.  
 
 
 
 
 
 
 
 
 
Figure 30. Conservation of parvovirus Rep protein motifs in SDEs. 
Amino acid alignment of the REP protein of AAV parvoviruses and different SDEs identified in 
Primates. Blue: exogenous dependoparvoviruses, yellow: SDEs found in the Cercopithecidae. 
Conservation regions of the REP domain involved in DNA binding and helicase activity (walker A 
and walker B) in Parvoviridae are compared between AAV and the SDEs found in Primates. Amino 
acid alignment was performed by Jalview (V: 2.8.2) program and types of amino acids are colored 
using Clustal mode. 
The alignment of SDEs with the parvovirus vp genes allowed identification of several conserved 
motifs characteristic to the structural proteins of Parvoviridae. For example, significant 
conservation of amino acids between SDEs and parvovirus structural proteins was found within 
the VP1 unique region, where cluster of basic residues are involved in virus traffic to the nucleus 
during cell entry (Lombardo et al., 2002; Tu et al., 2015; Vihinen-Ranta et al., 1997), (data not 
shown). The conservation of residues with important functional motifs of the VP proteins is shown 
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in Figure 31. The N-terminal VP1 unique region contains a phospholipase domain (PLP2) that is 
essential for parvovirus cell entry (Farr et al., 2005; Zádori et al., 2001). This PLP motif is 
remarkably present in the SDEs of Cercopithecidae. These SDEs domains show high homology with 
the PLP motifs of AAV, including the key residues involved in Ca++ binding and catalytic domains 
(Fig. 31, upper). However, the homology was much lower to best characterized phospholipases of 
human, primates and other origins (Fig. 31, lower). Therefore, this alignment also confirmed that 
the SDEs are of viral origin.  
 
 
 
 
 
 
 
 
Figure 31. Conservation of the PLP2 domain in SDEs.  
Upper: Amino acid alignment of PLP motifs of SDEs (yellow) compared to circulating AAV (blue), as 
well as (lower) human and primate genomics (green) phospholipases. The figure illustrates the 
overall conservation throughout the PLP2 motif among the viral sequences, and particularly at key 
residues (red triangles) involved in Ca++ binding and catalytic functions (based on Zádori et al., 
2001).  
 
4. The SDEs in the Parvoviridae phylogeny. 
As explained above, the SDEs identified in living primates correspond to viral elements 
homologous to the members of Dependoparvovirus genus of Parvoviridae, which have not been 
isolated as infectious entities. To perform a phylogenetic analysis of the SDEs within the current 
taxonomy of Parvoviridae (Cotmore et al., 2014), phylogenetic trees were constructed relating 
genomic fragments of the SDEs identified in primates with the homologous corresponding 
sequences of the rep gene of current exogenously circulating parvoviruses. As shown in Figure 32, 
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all Rep sequences of SDEs belonging to Cercopithecidae, phylogenetically clustered close to the 
AAV2 (member of the A species of AAV), the best characterized dependoparvovirus that is 
frequently found in human and monkey tissues. Other common dependoparvoviruses as AAV7 and 
AAV8 are also phylogenetically close to SDEs, whereas AAV5 and bird dependoparvoviruses are far 
related. Interestingly, the two SDEs found in Papio resulted in different clades: Pan3 next to Cat42, 
and Pan11 next to Cat60 and Mle, in consistency with their basic genetic structure (Figure 25).  
 
 
 
 
 
 
 
 
 
Figure 32. SDEs phylogeny.  
Phylogenetic relationships between the SDEs (yellow) and some currently circulating 
Dependoparvoviruses (blue). Avian and reptile dependoviruses were used as outgroups. The 
program MEGA7 was used to generate the phylogenetic tree, using the maximum likelihood 
method with 500 bootstraps. 
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Discussion  
Section A: 
1.Viral entry 
The successful virus entry pathway leading to infection involves complex series of interactions, 
from the cell surface receptor to the site of virus genome uncoating in a host cell compartment. 
Incoming virus particles must therefore traffic through multiple membranes and vesicles acting as 
cellular barriers, accounting for the low specific infectivity (Si) of viral systems (Ranging from 1 to 
as high as 10e5 particles per infectious entity; e.g. Carpenter et al., 2009), and  the characteristic 
host cell dependence (Flint et al., 2008). 
In the viral system analyzed in this work, the MVMt, a Threonine mutant constructed at non-
structural proteins of the immunosuppressive strain of minute virus of mice (MVMi), showed a Si 
more than two hundred times higher than that of the wt strain. This phenomenon was 
independent of the method used to measure physical virus particles (HA, TEM, or virus genomes), 
and the viral stocks were prepared in the same cell host along several years of research (Figure 9). 
This remarkably high Si, which to our knowledge is an unprecedented property for an engineered 
mutant virus, prompted us to address the mechanism(s) involved. Therefore, both the physical 
and chemical properties of viral capsids, and their early intracellular trafficking, were studied.   
A major concern in our analysis was to assess whether the increased Si observed in MVMt was due 
to NS protein functions, or it was mediated by the viral particles. Control transfections with the 
MVMi and MVMt infectious genomic plasmids showed similar viral genome replication levels in 
NB324K cells (under elaboration), suggesting similar NS protein activities in this cell type. 
Moreover, the drastic physico-chemical differences of the MVMi and MVMt purified viral particles 
in agarose gel, under normal and stress conditions (see below), strongly suggests that their 
characteristic Si is mainly due to inherent viral capsid properties.  
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1.1. Phosphorylation of MVMi and MVMt capsid subunits.  
A definitive evidence for different physical features between MVMi and MVMt capsids was 
obtained by analyzing the post-translational modifications of their protein subunits. Previous 
reports showed that the capsid subunits of MVMp, the prototype strain of MVM, are 
phosphorylated in Ser and Thr residues localized mainly at the VP2 n-terminus (Maroto et al., 
2000). This phosphorylation was necessary for virus egress (Maroto et al., 2004), and nuclear 
capsid assembly and maturation (Gil-Ranedo et al., 2018; Riolobos et al., 2010). On the other 
hand, negative charges in the viral surface were demonstrated to be important for nuclear export 
of MVMp, and removing of these charges by lambda phosphatase impaired the behavior of the 
virus in column chromatography (Wolfisberg et al., 2016).  
This study shows, for the first time, that the MVMi capsid subunits are also phosphorylated in vivo. 
Moreover, the phosphorylation level of the MVMt capsid proteins (VP1 and VP2) was higher than 
that of the MVMi (Figure 18A). The distinct phosphorylation levels correlated with the lower 
mobility in agarose gels of the MVMt empty capsid as well as the DNA-full particles in respect to 
the corresponding MVMi particles (Figure 13). This suggests that negative phosphate charges, (as 
it is well known for phosphoproteins) may lower viral particles migration under electrophoretic 
fields. Moreover, purified empty and DNA-filled viral particles treated with lambda phosphatase 
changed their behavior in gels (Figure 18B), demonstrating the contribution of phosphate 
substituents in the viral particles migration. However, further research will be required to 
determine the mechanisms connecting the NS protein mutation with the specific phosphorylation 
sites on MVMt capsid residues. This knowledge could allow us to understand the role of capsid 
phosphorylation on virus Si, and on viral particles electrophoretic mobility.    
1.2. Structural and biological responses to heat of the MVMi and MVMt viral particles.   
In search of properties that VP subunits phosphorylations may confer to the MVMi/t viral capsids 
that could explain their distinct Si, we focused on characterizing the structural and biological 
response of these viruses to heat in vitro. Highly purified empty and DNA-filled viral particles of 
both viruses were subjected to controlled temperature shifts (10 min) along a wide range of 
degrees, and then carefully inspected for integrity, configuration of capsid epitopes, behavior in 
native electrophoresis, hemagglutination capacity, genome uncoating and infectivity. The major 
changes in capsid configuration of the MVMi/t viruses in response to heat has been illustrated in 
Protected D ta 
PROTECTED DATA 
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Figure 33. It should be first emphasized that, in both viruses, the infectivity strictly paralleled the 
degree of ssDNA genome uncoating triggered by heat, regardless to the configuration of the other 
studied elements of capsid surface. However, other significant differences were observed between 
the capsid elements of the MVMi/t viruses, as discussed below.  
In TEM analysis of heat response (Figures 10 and 11), DNA-filled particles, but not empty capsids, 
were resistant to the penetration of uranile acetate stain in their interior. As temperature raised 
both viruses allowed some positive internal staining, in consistency with viral genome extrusion 
outside the capsid along these temperatures (Figure 15A). Thus, as reported for MVMp, the MVMi 
virus may tolerate some genome extrusion without capsid disassembly (Cotmore et al., 2010). The 
major MVMi/t difference by TEM analysis was observed at high temperatures, as MVMi remained 
essentially intact (although mostly stained) at 80 °C, whereas the MVMt virus lost particle integrity 
at this temperature in accordance with genome extrusion. Therefore, the increased capsid 
phosphorylation of MVMt (Figure 18) may regulate a genome uncoating coupled with capsid 
disassembly, a property with potential significance for its high in vivo Si. 
The analysis of virus HA capacity along temperature raise (Figure 12) also supported a higher 
stability of MVMi capsids than those of MVMt. Moreover, the HA study, compared to the TEM 
analysis, unraveled the remarkable capacity of viral capsids (mostly MVMi) to remain as intact 
physical particles in spite of their total loss of HA capacity. Clearly, the MVMi capsids remain 
assembled by subunit contacts in which HA domains are not involved. It was also interesting to 
find an identical full virus/empty capsid HA capacity at any temperature in both MVMi/t cases. 
This finding is in contrast with the stability conferred by the virus genome according to atomic 
force microscopy studies on MVMp (Carrasco et al., 2006), suggesting that the HA domains are 
neither involved in MVM capsid mechanical stiffness. The HA capacity of MVMi/t viruses along 
temperature raise however, strictly correlated with the reactivity of electro-blotted viral capsids to 
anti-MVM capsid polyclonal antibody (Figure 14). These two sets of experiments highly supported 
the concept that HA domains and conformation epitopes on MVM capsid surface overlap and 
likely share amino acid residues.  
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Figure 33. Model of the MVMi and MVMt viral particles structural responses to heat.  
The figure summarizes the major differences in the heat response of the MVMi and MVMt viruses 
found in this study. The decrease in the number of HAU, capsid epitopes and B7 3x epitope in both 
MVMi/t viruses along temperature raise has been quantitatively illustrated. The exposure of the 
VP2 N-terminal sequence out of the capsid, and the mean extrusion of ssDNA virus genome are 
also illustrated. The location of the HA domains and major epitopes on the capsid surface is 
uncertain. Drawing of capsids reflects TEM determinations. The MVMi and MVMt capsids were 
not seen at 85 °C and 80 °C, respectively (Figure 11). Although the progressive minor decrease in 
intact virus particles as temperature raised up to 75 °C has not been quantitatively illustrated.  
 
This study also provides novel insights into MVM virus configuration leading to capsid disassembly. 
MVMi/t viral particles integrity as temperature raised may be accounted by prevalence of 
structured capsid epitopes on the surface, including the best characterized B7-Mab epitope at the 
3x axis (López-Bueno et al., 2003). Importantly, the resistance of MVMi virus at high temperature 
was corresponded by the prevalence of the B7 reactivity, which was not observed in MVMt (Figure 
14), strongly suggesting that the stability of this epitope, configured by residues of three 
interdigitated VP subunits (Kaufmann et al., 2007), is lowered by MVMt capsid phosphorylation. 
Nevertheless, it is difficult to assess which VP complex catalyzes the final MVMi/t viral capsid 
disassembly by heat in vitro, because VP trimers did not conserve the B7 epitope outside of the 
capsid (Riolobos et al., 2010). Trimers were suggested to catalyze disassembly of VLPs treated with 
high concentration of guanidine in vitro (Medrano et al., 2016), although the characterization of 
the disassembled VP complexes was limited. Anyhow, that study is far related to our current 
analyses since the capsid-disassembly agent (guanidine/heat) differed, and VLPs devoid of the VP1 
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subunits and the phosphorylated VP2 residues that are necessary for native MVM nuclear capsid 
assembly in mammalian cells (Riolobos et al., 2010). MVMt capsid disassembly was remarkably 
coupled to genome uncoating (Figure 33), therefore the putative VP complexes remain modified 
and should be analyzed in the context of ssDNA interaction. In MVMi the final viral stage just prior 
to in vitro disassembly is an unstable empty capsid, which is unable to withstand agarose 
electrophoresis. This capsid is lacking the HA domains and structured epitopes, and it is likely 
maintained as physical particle by the beta-barrel folding at the core of the subunits (Rossmann 
and Johnson, 1989). Whether this capsid entity finally disassembles as individual subunits, or some 
type of VP complexes, is uncertain.  
The exposure out of the coat of the VP2 N-terminal domain (2Nt) was also a clearly distinct marker 
of the different MVMi/t heat-induced structural responses. Previous reports showed that native 
empty capsids, as well as VLPs of MVMp, irreversibly exposed 2Nt in respond to heat since 50-60 
°C to higher temperatures (Carreira et al., 2004; Hernando et al., 2000; Riolobos et al., 2010). 
However, DNA-filled MVMp virus failed to do so as the infectivity was inactivated at high 
temperatures (Sánchez-Martínez et al., 2012). In the present report the analysis on 2Nt exposure 
however was complemented by additional comprehensive studies on capsid configurations, which 
showed that in MVMi, although 2Nt exposure is blocked at high temperatures as well (figure 16), 
the infectivity rather correlated with genome uncoating (Figure 15). Another important 
observation of the present study is the dissociation of 2Nt exposure with the overall heat-induced 
capsid configuration shift, as major loss of capsid epitopes and HA domains occurred at 
temperatures above 60 °C when the 2Nt exposure is blocked (Figure 33). These data dissect the 
phenomenon of MVM capsid structural transitions as a succession of events much more complex 
than the unique structural transition through the 50-60 °C interval previously suggested by 
tryptophan fluorescence (Castellanos et al., 2013). Most important is the observation on VP2/3 
cleavage of MVMt described in Figure 16, showing that the 2Nt exposure in this virus is highly 
efficient and temperature independent. These data further support that VP phosphorylation 
confers an increased structural plasticity to the MVMt viral capsid, which may bring advantageous 
properties for intracellular virus traffic in the infection.  
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1.3. Role of the low endosomal pH in MVMi and MVMt cell entry capacity. 
Interestingly, some of our preliminary in vitro studies suggested that pH may severely affect 
MVMi/t infection properties. As observed in Figure 17A, the low pH prevented MVMi genome 
uncoating in response to heat, but it greatly benefited its Si at the same temperatures (Figure 
17B). Remarkably, this pH beneficial effect on infection was not apparent for MVMt virions treated 
under the same conditions (Figure 17). The significance of this observation for the infection is 
difficult to assess, but it may be speculated that MVMi is over-stabilized at low pH that eventually 
prevents structural transitions of the incoming virions necessary to infect.  
A distinct pH effect may also sustain some of our observations performed in the MVMi/t natural 
infection. It was reported that MVMp requires low endosomal pH for the infection (Mani et al., 
2006; Ros et al., 2002). This requirement was also observed for MVMi here in the same cell type 
(NB324K cells), as drugs that raise endosomal pH (NH4Cl, or Chloroquine) did drastically inhibit 
MVMi infection measured by NS1 expressing cells (Figure 19). Of note, the inhibition of virus gene 
expression by the endosomal drugs, in infections performed at the same multiplicity (PFU/cell), 
was significantly higher at certain concentration for MVMt than for MVMi (Figure 19). Although 
still preliminary, these data may suggest that the high Si of MVMt requires low pH for efficient 
trafficking along the endosomal compartments. This hypothesis is currently under investigation 
with additional drugs and assays, particularly whether the endosomal escape may differ timely or 
by distinct capsid structural dynamics between both viruses. 
 Finally, the successful MVM infection necessarily leads to the delivery of the virus ssDNA 
genome into the nucleus. It would be therefore expected that the higher Si, more than two 
hundred folds, of MVMt in respect to MVMi results in a substantially increased nuclear delivery of 
the MVMt genome. We have tried to analyze the subcellular distribution of virus components 
during entry, but the outcome was unclear. Firstly, the genome of both viruses seemed to remain 
associated to the incoming capsid in a similar pattern after different hours post infection (Figure 
20), suggesting that a premature MVMi uncoating may not be the key difference between these 
viruses. Secondly, a careful IF analysis by confocal microscopy staining capsid proteins, intact 
capsid, or viral DNA performed at high multiplicity of infection did not allow the detection of viral 
components at early time points (0-6 hpi) inside the nucleus. Rather, both MVMi and MVMt 
macromolecules were accumulated at the nuclear periphery without significant nuclear invasion 
(Figure 22). These results may suggest a saturation of the cellular transport system by the amount 
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of viral particles used in this set of experiments. Unfortunately, other experiments performed with 
lower amounts of input virus did not allow clear IF staining of viral components (data not shown). 
In conclusion, other more sensitive methods will be required to study the presumed differential 
nuclear entry of MVMi/t genomes at low multiplicity of infection.    
 
Section B 
1. Endogenous Viral Elements (EVEs)  
Mostly RNA, but some DNA viruses as well, may infect germ line cells along evolution and become 
integrated into their chromosomes and inherited as endogenous virus elements (reviewed in 
Feschotte and Gilbert, 2012). Most identified endogenous ssDNA virus elements (ESVEs) belong to 
the Parvoviridae (Arriagada and Gifford, 2014; Belyi et al., 2010; Kapoor et al., 2010; Katzourakis 
and Gifford, 2010; Liu et al., 2011), a family of viruses that, as explained in introduction, 
successfully infects hosts belonging to the three domains of life. The increasing availability of 
genomic sequences and annotations in data bases prompted us to search for ESVEs in primates.  
 
2. Presence of ESVEs in non-human primate genomes. 
This work describes the first in depth in silico analysis, supported by molecular characterizations, 
of genetic elements of the ssDNA viruses inserted in the germ line (ESVEs) of some currently living 
primates. The elements were designated as Simian Dependoparvovirus Elements (SDEs), as they 
reflect the insertion of uncharacterized parvoviruses of the Dependoparvovirus genus of the 
Parvoviridae, which must have circulated (or are still circulating) as exogenous infectious agents in 
primates prior endogenization. It should be emphasized that these SDEs correspond only to those 
genetic elements found with E-values equal or less than 1e-10, the threshold that we set as 
significant, but it may be possible that other SDE(s) with less significance, or genomically spread 
sequences with reminiscence of parvoviruses genomes be found in future searches.  
Our wide search of ESVEs in primates resulted in multiple SDEs of the Parvoviridae. This finding 
supports other studies that highlighted the dominant relevance of a parvoviral origin for the 
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collection of ssDNA virus elements found in many prokaryotic and eukaryotic organisms 
(Katzourakis and Gifford, 2010). This predominance of SDEs elements is remarkable and suggests 
biological inherent properties of parvoviruses promoting or favouring their germinal insertion. It 
may be suggested that the efficient endogenization of these ssDNA viruses is related to the rolling-
circle mechanism of replication (Tattersall and Ward, 1976) and their insertional mechanisms in 
non-productive infection (Samulski et al., 1991). Moreover, other possible factors could favor the 
successful endogenization of parvoviruses, such as their nuclear life cycle (Cotmore and Tattersall, 
2007), the capacity to persist as non-toxic infectious entities in growth-arrested cells (Gil-Ranedo 
et al., 2015), the systemic infection and blood transmision (Qiu et al., 2017), and their capacity to 
infect stem cells in tissues (Segovia et al., 2003). 
 
3. ESVEs insertion events throughout primate evolutionary history. 
We have found ESVE of the Parvoviridae that has been endogenized in certain families of 
Primates. A summary of our collection data is illustrated in Fig. 34. No ssDNA virus endogenization 
were identified in the new world monkeys (Platyrrhini), neither in the Lorisiodea (Galagidae and 
Lorisidae families) or Hominicidae (Hylobatidae and Hominidae families) superfamilies of primates. 
Three families of primates, the Atelidae, Pithecidae (belonging to the new world monkeys 
Platyrrhini) and the Strepsirrhini were not analyzed due to unavailability of DNA samples and the 
lack of DNA sequence information in databases.  
A total number of four independent endogenization events of ESVEs were localized in genomes of 
currently living primates. The precise number of SDE insertion sites could be deduced from their 
genetic structure and primate phylogeny. Usually a single SDE or in some cases two SDEs were 
found in several primate genera of the Cercopithecidae family. The genetic structure and 
phylogeny data indicated that the endogenization events leading to SDEs occurred after the split 
of the Haplorrhini and Strepsirrhini primates. 
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Figure 34. Insertion events of AAV elements in the Haplorrhini primate genomes along evolution 
The figure illustrates the genera of the Primates phylogeny (adapted from Perelman et al., 2011) 
tested in this report for the presence of endogeneous parvovirus elements (SDE) by in silico and/or 
molecular analyses. Arrows mark the identified endogenization events illustrated by coloured 
capsids at branches of primate phylogeny. The SDEs are shown in one primate species of each 
genus. In those primate genera carrying two SDE a single species representing each type of 
insertion is shown. Illustrations and approximate geographical distribution of African primates are 
from Petter and Desbordes, 2010.  
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4. The origin of SDEs  
The origin of the endogenized AAV cannot be traced easily. Lower evolutionary rates of 
endogenous viruses in respect to circulating viruses have been decribed (Feschotte and Gilbert, 
2012) and must be taken into account. Interestingly, the SDEs found in the primate species of the 
Cercopithecidae are much closer to the AAV2 parvovirus (Figure 32). Although these homologies 
do not imply how old the SDEs are, distinct origin(s) among them seems likely; However, they do 
not indicate the host range of the ancient circulating endogenized AAV since the tropism 
determinants of parvoviruses could rely on a few distinct amino acids (Cotmore and Tattersall, 
2007; López-Bueno et al., 2006; Parrish, 2010). Different Dependoparvoviruses may have been 
endogenized as the primate speciations occurred, about 40-60 million years ago, paralleling the 
different patterns of primate species in the main land of the African continent (Cercopithecidae). 
5. Evolutionary implications of ESVE insertions across primate phylogeny. 
Although our study included most primate genomes available in 2016/17 databases, as well as 
some DNA samples from primates not sequenced yet, it is possible that when the sequence of 
other primate genomes became available, particularly Asian Cercopithecidae and the new world 
monkeys (Platyrrhini), the overall presence of SDEs in the biosphere became notoriously enlarged. 
Some evolutionary implications of SDEs for the dynamics of primate genomes can be 
hypothesized. The presence of two distinct SDEs in Papio and Cercocebus, with identical structures 
was confirmed by genome analysis and PCR amplifications (Figure 25-29) but the existance of only 
the shorter SDE in Mandrillus leucophaeus, cannot be accommodated with the best stablished 
primates phylogenetic tree, as Mandrillus and Cercocebus are closer than Papio (Perelman et al., 
2011). These observations may suggest the loss of the  larger SDE locus in Mandrillus which would 
support a high dynamic and plasticity of the primate genomes.  
6. Parvovirus endogenization mechanism(s) 
In eukaryots, most viral endogenization mechanisms operate from RNA messengers or input RNA 
virus genomes, which are converted to dsDNA at certain stages of virus life cycle. It has been 
known for decades that the Retroviridae ssRNA+ genome is reverse-transcribed and integrated to 
initiate infection. Endogenous retrovirus elements (ERVs) may be generated through a diversity of 
molecular rearrangements (Feschotte and Gilbert, 2012) and can be subsequently mobilized, by 
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reverse-transcription activities, in thousands of copies across the invaded genome. Other RNA 
viruses, lacking reverse transcriptase, may be endogenized via cellular retrotransposons acting on 
viral RNA transcripts generated in the infection. For example, the endogenous elements of 
Bornaviruses were corresponded to pseudogenes flanked by repeat sequences and polyA 
stretches indicative of LINE-1 retrotranscription activity (Horie et al., 2010). However, endogenized 
virus genes lacking traces of LINE-1 activity could also be identified. It was suggested that other 
RNA virus families might follow different endogenization pathways. The mechanism(s) of DNA 
virus endogenizations are largerly unknown, although it is belived that generally a RNA molecule is  
served as an intermediate (Katzourakis and Gifford, 2010).  
This study shows that parvovirus colonization of primate germ lines likely involved a different 
pattern of DNA-mediated insertional mechanism(s). All the identified SDEs conserve cis-acting 
regulatory sequences, which are not present in the Dependoparvovirus transcripts. For example 
the 5´-ITR, P5, and P19 promoters are conserved in many SDEs of the Cercopithecidae (Figure 25). 
Also most SDEs do conserve introns. Collectively, these genetic features delineate an 
endogenization mechanism that is driven by the incoming ssDNA parvovirus genome, or a dsDNA 
replicative intermediate.  
AAV replicative intermediates and other DNA forms are naturally found accumulated in 
mammalian tissues, notably in human and non-human primates (Gao et al., 2004; Schnepp et al., 
2005). Also other parvovirus DNA forms may persist in experimental conditions (Segovia et al., 
2003), which could eventually favour a recombination process with host genome. Interestingly, an 
insertional mutagenesis caused by AAV elements in mice and humans lead to hepatocarcinoma 
(Donsante et al., 2007; Nault et al., 2015). The machinery responsible of SDE insertions is largerly 
unknown. Uncovering this machinery may help us understand why some species are better 
substrate for genome colonization, and also it could contribute to the development of safer 
Dependoparvovirus based vectors for human and primate gene therapy. 
7. Perspectives 
Clearly, further and extensive research is required prior to a comprehensive understanding of the 
functional role(s) that the SDEs may, or may not have, in the evolution of primates. The successful 
colonization of the genome of several primates families by AAV opens new perspectives for the  
future evolution of human and non-human primates. The prevalence of AAV circulating as 
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infectious entities in human (Gao et al., 2004; Schnepp et al., 2005) and Primates (Gao et al., 2003, 
2004) is very high. Although we have been unable to detect ESVEs in the available genomes of 
Hominidae (neither in a collection of human samples), the high rate of circulating AAV as well as its 
widely demonstrated capacity to become inserted in human cells and tissues (Hüser et al., 2010; 
Janovitz et al., 2013; Kotin et al., 1992; Samulski et al., 1991), and to colonize the germ line of 
many animals (Katzourakis and Gifford, 2010) and primates (this study), allow us to anticipate that 
endogenization of AAV will continue to occur, resulting in ESVE in future or currently living 
individual and certain human populations. A likely ongoing phenomenon which may shape the 
genome and perhaps contribute to future evolution of human and non-human primates. 
  
 
  
Conclusions 
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1. An electrophoretic-blot method for viral particle analysis, set-up in this study, allows the 
resolution of MVM empty and DNA-filled viral particles, as well as tracing some shifts in capsid 
stability and configuration. 
2. The VP2-Nt sequence exposure out of the capsid coat contributes to the heterogeneous 
electrophoretic mobility of the DNA-filled MVM virions in agarose gels. 
3. The DNA-filled MVMt mutant virus exhibits more pronounced exposure dynamics of the 2Nt 
and 1Nt sequences than those of the MVMi wild type virus, accounting for its increased 
heterogeneous mobility in gels.   
4. The biological and physicochemical properties of MVMi and MVMt full viruses and empty 
capsids respond differently to heat under neutral and acidic pH conditions.   
5. Newly synthesized and assembled capsid subunits are modified by phosphates to a different 
extent in the MVMi versus the MVMt viruses. This phosphorylation contributes to the distinct 
electrophoretic mobility of these viral particles in agarose gels, and presumably to the other 
physical and biological properties described in this study.   
6. The higher killing capacity of human cancer cells by MVMt in respect to that of MVMi is 
related, at least in part, to a differential trafficking through the endosomal network.  
7. Nine genetic endogenous elements of the Parvoviridae, here named Simian 
Dependoparvovirus Elements (SDEs), were characterized in the genome of primates belonging 
to the Cercopithecidae. 
8. The SDEs show a high level of nucleotide and amino acid identity with currently circulating 
virus members of the Dependoparvovirus.  
9. A phylogenetic relationship has been established between the SDEs and the currently 
circulating Dependoparvovirus genomes. 
10. We propose four independent invasions of primate genomes by parvoviruses along 
evolution. 
PROTECTED DATA 
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1. Un método de electroforesis en agarosa y transferencia a filtros, elaborado en este estudio, 
permite la resolución de partículas víricas de MVM vacías y llenas de ADN, así como detectar 
cambios en la estabilidad y configuración de las cápsidas. 
2. La exposición de la secuencia VP2-Nt fuera de la cápsida contribuye a la movilidad 
electroforética heterogénea en geles de agarosa de los viriones MVM llenos de ADN. 
3. El virus mutante MVMt lleno de ADN exhibe una dinámica de exposición más pronunciada de 
las secuencias 2Nt y 1Nt que las del virus silvestre MVMi, lo que explica la mayor heterogeneidad 
en su migración en geles de agarosa. 
4. Las propiedades biológicas y fisicoquímicas de los virus completos MVMi y MVMt, así como de 
sus cápsidas vacías, responden de manera diferente al calor en condiciones de pH neutro y ácido. 
5. Las subunidades de proteínas recién sintetizadas y ensambladas en cápsidas están modificadas 
por fosfatos en diferente medida en los virus MVMi y MVMt. Esta fosforilación contribuye a una 
distinta movilidad electroforética de las partículas virales en geles de agarosa y probablemente a 
las otras propiedades físicas y biológicas descritas en este estudio. 
6. El incremento en la capacidad de matar células cancerosas humanas por el virus MVMt, con 
respecto a la del MVMi, está relacionada, al menos en parte, con un tráfico diferente a través de la 
red endosomal. 
7. Se han caracterizado nueve elementos genéticos endógenos de Parvoviridae, aquí llamados 
Elementos de Dependoparvovirus de simio (EDS, o SDE), en el genoma de primates pertenecientes 
a la familia Cercopithecidae. 
8. Los SDE muestran un alto nivel de identidad de nucleótidos y aminoácidos con algunos virus 
circulantes en la actualidad del género Dependoparvovirus. 
9. Se ha establecido una relación filogenética entre los SDE y los genomas de los 
Dependoparvoviruses actualmente circulantes. 
10. Proponemos cuatro invasiones independientes de genomas de Primates por parvovirus a lo 
largo de la evolución.  
 
DATOS PROTEGIDOS 
  
 
 دنتفگیتفا میدوشن هتشگایم ام 
تفگ نآک یتفا میدوشن تسوزرآ منآ 
 ،انلاوم( ۶۰۴  یلا۶۷۲  یرمق) 
 
 
 
 
 
 
 
Dedicated to Pepe: 
 
They said, “It is not to be found; we have searched too.”  
He answered, “the thing who is not to be found is my desire.” 
 
 
 
Dijeron, "No se encuentra, nosotros también lo hemos buscado".  
Respondió, "lo que no se encuentra es mi deseo". 
 
Rumi (Molana), Persian Poet (1207- 1273) 
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